KR101940019B1 - 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 - Google Patents
항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 Download PDFInfo
- Publication number
- KR101940019B1 KR101940019B1 KR1020170077537A KR20170077537A KR101940019B1 KR 101940019 B1 KR101940019 B1 KR 101940019B1 KR 1020170077537 A KR1020170077537 A KR 1020170077537A KR 20170077537 A KR20170077537 A KR 20170077537A KR 101940019 B1 KR101940019 B1 KR 101940019B1
- Authority
- KR
- South Korea
- Prior art keywords
- bacteriophage
- present
- ymc16
- ymc15
- klebsiella
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title claims abstract description 106
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 31
- 241000588748 Klebsiella Species 0.000 title abstract description 27
- 229940088710 antibiotic agent Drugs 0.000 title description 18
- 230000002101 lytic effect Effects 0.000 title description 4
- 230000003115 biocidal effect Effects 0.000 claims abstract description 54
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 10
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000000645 desinfectant Substances 0.000 claims description 8
- 241000702202 Siphoviridae Species 0.000 claims description 4
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 241000588754 Klebsiella sp. Species 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 230000002147 killing effect Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 25
- 239000008194 pharmaceutical composition Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 18
- 239000000203 mixture Substances 0.000 description 15
- 235000013305 food Nutrition 0.000 description 14
- 229940096118 ella Drugs 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 206010035664 Pneumonia Diseases 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 101100283436 Human herpesvirus 8 type P (isolate GK18) gM gene Proteins 0.000 description 5
- 101150016564 ORF39 gene Proteins 0.000 description 5
- 101100378791 Paenarthrobacter nicotinovorans aldh gene Proteins 0.000 description 5
- 101710134973 Uncharacterized 9.7 kDa protein in cox-rep intergenic region Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 101150075249 ORF40 gene Proteins 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 101100156835 Paenarthrobacter nicotinovorans xdh gene Proteins 0.000 description 4
- 102100040307 Protein FAM3B Human genes 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 3
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 3
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 3
- JUZNIMUFDBIJCM-ANEDZVCMSA-N Invanz Chemical compound O=C([C@H]1NC[C@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)NC1=CC=CC(C(O)=O)=C1 JUZNIMUFDBIJCM-ANEDZVCMSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- -1 Levoflocacin Chemical compound 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960004821 amikacin Drugs 0.000 description 3
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 3
- 229960003644 aztreonam Drugs 0.000 description 3
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 3
- 229960001139 cefazolin Drugs 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 229960002770 ertapenem Drugs 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229960002260 meropenem Drugs 0.000 description 3
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- LITBAYYWXZOHAW-XDZRHBBOSA-N (2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]hept Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 LITBAYYWXZOHAW-XDZRHBBOSA-N 0.000 description 2
- MMRINLZOZVAPDZ-LSGRDSQZSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride Chemical compound Cl.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 MMRINLZOZVAPDZ-LSGRDSQZSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 101000870242 Bacillus phage Nf Tail knob protein gp9 Proteins 0.000 description 2
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 2
- 101700012268 Holin Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 101710118890 Photosystem II reaction center protein Ycf12 Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 101710198378 Uncharacterized 10.8 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229940043312 ampicillin / sulbactam Drugs 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960002100 cefepime Drugs 0.000 description 2
- 229960004261 cefotaxime Drugs 0.000 description 2
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 2
- 229960002682 cefoxitin Drugs 0.000 description 2
- 229960000484 ceftazidime Drugs 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- NWOYIVRVSJDTLK-YSDBFZIDSA-L disodium;(2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(1r,4s)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylate Chemical compound [Na+].[Na+].O=S1(=O)C(C)(C)[C@H](C([O-])=O)C2C(=O)C[C@H]21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 NWOYIVRVSJDTLK-YSDBFZIDSA-L 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- CEAZRRDELHUEMR-UHFFFAOYSA-N gentamicin Chemical compound O1C(C(C)NC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N CEAZRRDELHUEMR-UHFFFAOYSA-N 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007913 intrathecal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229940104641 piperacillin / tazobactam Drugs 0.000 description 2
- 230000007505 plaque formation Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 101710115267 ATP synthase protein MI25 Proteins 0.000 description 1
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 1
- 101000748061 Acholeplasma phage L2 Uncharacterized 16.1 kDa protein Proteins 0.000 description 1
- 101000818123 Acholeplasma phage L2 Uncharacterized 17.2 kDa protein Proteins 0.000 description 1
- 101000818089 Acholeplasma phage L2 Uncharacterized 25.6 kDa protein Proteins 0.000 description 1
- 101000827329 Acholeplasma phage L2 Uncharacterized 26.1 kDa protein Proteins 0.000 description 1
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000818108 Acholeplasma phage L2 Uncharacterized 81.3 kDa protein Proteins 0.000 description 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
- 101000748781 Anthoceros angustus Uncharacterized 3.0 kDa protein in psbT-psbN intergenic region Proteins 0.000 description 1
- 101000812031 Anthoceros angustus Uncharacterized 5.9 kDa protein in rps16-psbA intergenic region Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 101100214868 Autographa californica nuclear polyhedrosis virus AC54 gene Proteins 0.000 description 1
- 101100074342 Autographa californica nuclear polyhedrosis virus LEF-11 gene Proteins 0.000 description 1
- 101100351191 Autographa californica nuclear polyhedrosis virus PCNA gene Proteins 0.000 description 1
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 1
- 101000770875 Autographa californica nuclear polyhedrosis virus Uncharacterized 14.2 kDa protein in PK1-LEF1 intergenic region Proteins 0.000 description 1
- 101000781183 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.4 kDa protein in IAP1-SOD intergenic region Proteins 0.000 description 1
- 101000847476 Autographa californica nuclear polyhedrosis virus Uncharacterized 54.7 kDa protein in IAP1-SOD intergenic region Proteins 0.000 description 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 1
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
- 101000736075 Bacillus subtilis (strain 168) Uncharacterized protein YcbP Proteins 0.000 description 1
- 101000736076 Bacillus subtilis (strain 168) Uncharacterized protein YcbR Proteins 0.000 description 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
- 101000786247 Bacillus subtilis (strain 168) Uncharacterized protein YqaT Proteins 0.000 description 1
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 1
- 101000774107 Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM 4680) Uncharacterized protein BB_0266 Proteins 0.000 description 1
- 101000631235 Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM 4680) Uncharacterized protein BB_0268 Proteins 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 1
- 101000736909 Campylobacter jejuni Probable nucleotidyltransferase Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101000748745 Chlamydomonas reinhardtii Uncharacterized 6.2 kDa protein in psaC-petL intergenic region Proteins 0.000 description 1
- 101000626907 Chlamydomonas reinhardtii Uncharacterized 7.3 kDa protein in petA 5'region Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 1
- 101000947615 Clostridium perfringens Uncharacterized 38.4 kDa protein Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100039200 Constitutive coactivator of PPAR-gamma-like protein 2 Human genes 0.000 description 1
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 101000792449 Cyanophora paradoxa Uncharacterized 3.4 kDa protein in atpE-petA intergenic region Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101150026402 DBP gene Proteins 0.000 description 1
- 102000003844 DNA helicases Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102100024101 DnaJ homolog subfamily C member 28 Human genes 0.000 description 1
- 101000747774 Enterobacteria phage 82 Uncharacterized protein in rusA 3'region Proteins 0.000 description 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 101000964391 Enterococcus faecalis UPF0145 protein Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
- 101100173936 Escherichia coli (strain K12) flmA gene Proteins 0.000 description 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 1
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
- 101000748786 Euglena longa Uncharacterized 7.2 kDa protein in rps2-rps9 intergenic region Proteins 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 208000034347 Faecal incontinence Diseases 0.000 description 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 101000626903 Guillardia theta Uncharacterized 6.1 kDa protein Proteins 0.000 description 1
- 101000792437 Guillardia theta Uncharacterized 7.8 kDa protein Proteins 0.000 description 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
- 101000912350 Haemophilus phage HP1 (strain HP1c1) DNA N-6-adenine-methyltransferase Proteins 0.000 description 1
- 101000933958 Haemophilus phage HP1 (strain HP1c1) Major capsid protein Proteins 0.000 description 1
- 101000743338 Haemophilus phage HP1 (strain HP1c1) Probable head completion/stabilization protein Proteins 0.000 description 1
- 101001066788 Haemophilus phage HP1 (strain HP1c1) Probable portal protein Proteins 0.000 description 1
- 101001052021 Haemophilus phage HP1 (strain HP1c1) Probable tail fiber protein Proteins 0.000 description 1
- 101000854890 Haemophilus phage HP1 (strain HP1c1) Probable terminase, ATPase subunit Proteins 0.000 description 1
- 101000743335 Haemophilus phage HP1 (strain HP1c1) Probable terminase, endonuclease subunit Proteins 0.000 description 1
- 101000748063 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 11.1 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000758973 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 11.3 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000758963 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 12.7 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000976893 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 14.1 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
- 101000818057 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 14.9 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000818121 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 18.2 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000786896 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000708358 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 23.3 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000786921 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 26.0 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000948764 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 58.7 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000768945 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 7.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101000748060 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.3 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000977016 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101000623276 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiBIM 5'region Proteins 0.000 description 1
- 101000623175 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiCIIM 5'region Proteins 0.000 description 1
- 101000626850 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiEIM 5'region Proteins 0.000 description 1
- 101000748192 Herpetosiphon aurantiacus Uncharacterized 15.4 kDa protein in HgiDIIM 5'region Proteins 0.000 description 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
- 101001053999 Homo sapiens DnaJ homolog subfamily C member 28 Proteins 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101001028836 Homo sapiens M-phase-specific PLK1-interacting protein Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 101000652805 Homo sapiens Protein shisa-8 Proteins 0.000 description 1
- 101000820589 Homo sapiens Succinate-hydroxymethylglutarate CoA-transferase Proteins 0.000 description 1
- 101000667300 Homo sapiens WD repeat-containing protein 19 Proteins 0.000 description 1
- 101100064352 Human herpesvirus 8 type P (isolate GK18) DUT gene Proteins 0.000 description 1
- 101100100297 Human herpesvirus 8 type P (isolate GK18) TRM3 gene Proteins 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
- 238000002768 Kirby-Bauer method Methods 0.000 description 1
- 101000578717 Klebsiella pneumoniae Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 1
- 101000957786 Klebsiella pneumoniae Phosphomannomutase Proteins 0.000 description 1
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 1
- 101001015100 Klebsiella pneumoniae UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase Proteins 0.000 description 1
- 101000790838 Klebsiella pneumoniae UPF0053 protein in cps region Proteins 0.000 description 1
- 101000790837 Klebsiella pneumoniae Uncharacterized 18.9 kDa protein in cps region Proteins 0.000 description 1
- 101000790844 Klebsiella pneumoniae Uncharacterized 24.8 kDa protein in cps region Proteins 0.000 description 1
- 101000790840 Klebsiella pneumoniae Uncharacterized 49.5 kDa protein in cps region Proteins 0.000 description 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
- 101000790842 Klebsiella pneumoniae Uncharacterized 65.4 kDa protein in cps region Proteins 0.000 description 1
- 101000768313 Klebsiella pneumoniae Uncharacterized membrane protein in cps region Proteins 0.000 description 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
- 101000904276 Lactococcus phage P008 Gene product 38 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 101000756286 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 10.9 kDa protein in LEF8-FP intergenic region Proteins 0.000 description 1
- 101000759330 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized protein in LEF8-FP intergenic region Proteins 0.000 description 1
- 102100037185 M-phase-specific PLK1-interacting protein Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101000626970 Marchantia polymorpha Uncharacterized 3.3 kDa protein in psbT-psbN intergenic region Proteins 0.000 description 1
- 101000626905 Marchantia polymorpha Uncharacterized 3.8 kDa protein in ycf12-psaM intergenic region Proteins 0.000 description 1
- 101000748779 Marchantia polymorpha Uncharacterized 6.4 kDa protein in atpA-psbA intergenic region Proteins 0.000 description 1
- 101000747938 Marchantia polymorpha Uncharacterized mitochondrial protein ymf31 Proteins 0.000 description 1
- 101000747949 Marchantia polymorpha Uncharacterized mitochondrial protein ymf32 Proteins 0.000 description 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
- 101000804418 Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) Uncharacterized protein MTH_1463 Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 1
- 241001072332 Monia Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
- 102100023897 NADPH-cytochrome P450 reductase Human genes 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 101100521838 Nicotiana tabacum pbf1 gene Proteins 0.000 description 1
- 101150101223 ORF29 gene Proteins 0.000 description 1
- 101150020791 ORF37 gene Proteins 0.000 description 1
- 101150006817 ORF43 gene Proteins 0.000 description 1
- 101150050790 ORF49 gene Proteins 0.000 description 1
- 101150104094 ORF52 gene Proteins 0.000 description 1
- 101150098690 ORF54 gene Proteins 0.000 description 1
- 101710087110 ORF6 protein Proteins 0.000 description 1
- 101150088336 ORF9 gene Proteins 0.000 description 1
- 101100389785 Orgyia pseudotsugata multicapsid polyhedrosis virus ETM gene Proteins 0.000 description 1
- 101100069690 Orgyia pseudotsugata multicapsid polyhedrosis virus GTA gene Proteins 0.000 description 1
- 101100306237 Orgyia pseudotsugata multicapsid polyhedrosis virus LEF-8 gene Proteins 0.000 description 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
- 101100096140 Orgyia pseudotsugata multicapsid polyhedrosis virus SOD gene Proteins 0.000 description 1
- 101000666843 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 24.0 kDa protein Proteins 0.000 description 1
- 101000770899 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 24.3 kDa protein Proteins 0.000 description 1
- 101000781204 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 36.6 kDa protein Proteins 0.000 description 1
- 101000770870 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000805098 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 73.1 kDa protein Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
- 101100481711 Pneumococcus phage Dp-1 TMP gene Proteins 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 108050005751 Portal proteins Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 101710197985 Probable protein Rev Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
- 101710167869 Putative major capsid protein Proteins 0.000 description 1
- 108090000944 RNA Helicases Proteins 0.000 description 1
- 102000004409 RNA Helicases Human genes 0.000 description 1
- 241000588746 Raoultella planticola Species 0.000 description 1
- 241000588756 Raoultella terrigena Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 1
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 1
- 101000748499 Rhodobacter capsulatus Uncharacterized 104.1 kDa protein in hypE 3'region Proteins 0.000 description 1
- 101000748505 Rhodobacter capsulatus Uncharacterized 16.1 kDa protein in hypE 3'region Proteins 0.000 description 1
- 101000827754 Rhodobacter capsulatus Uncharacterized 5.8 kDa protein in puhA 5'region Proteins 0.000 description 1
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
- 101000814063 Salmonella phage P22 Uncharacterized 6.6 kDa protein in eae-abc2 intergenic region Proteins 0.000 description 1
- 101000992423 Severe acute respiratory syndrome coronavirus 2 Putative ORF9c protein Proteins 0.000 description 1
- 108050008741 Signal peptide peptidase A Proteins 0.000 description 1
- 241000543700 Staphylococcus virus Twort Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 1
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
- 101000708364 Streptomyces griseus Uncharacterized 31.2 kDa protein in rplA-rplJ intergenic region Proteins 0.000 description 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 1
- 102100021652 Succinate-hydroxymethylglutarate CoA-transferase Human genes 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 1
- 101000764204 Trieres chinensis Uncharacterized 3.3 kDa protein in rpl11-trnW intergenic region Proteins 0.000 description 1
- 101000792450 Trieres chinensis Uncharacterized 4.7 kDa protein in ycf33-trnY intergenic region Proteins 0.000 description 1
- 101000748762 Trieres chinensis Uncharacterized 5.4 kDa protein in trnK-psbC intergenic region Proteins 0.000 description 1
- 101000626900 Trieres chinensis Uncharacterized 5.5 kDa protein in ccsA-rps6 intergenic region Proteins 0.000 description 1
- 101000768114 Triticum aestivum Uncharacterized protein ycf70 Proteins 0.000 description 1
- 101710173665 Uncharacterized 5.8 kDa protein Proteins 0.000 description 1
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 1
- 101710172361 Uncharacterized protein ycf17 Proteins 0.000 description 1
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 102100039744 WD repeat-containing protein 19 Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 201000007047 acrodysostosis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 108010068385 carbapenemase Proteins 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000010218 electron microscopic analysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108010055246 excisionase Proteins 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007919 intrasynovial administration Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001320 lysogenic effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 101150055367 orf47 gene Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229960003865 tazobactam Drugs 0.000 description 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/127—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Dentistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 항생제에 대한 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균시키는 박테리오파지에 관한 것으로, 구체적으로는 서열번호 2 내지 4로 표시되는 유전체를 포함하는 YMC16/01/N133_KPN_BP 박테리오파지 (기탁번호: [KCTC18575P])를 제공한다.
본 발명에서 제공하는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 가지므로, 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 활용할 수 있다.
본 발명에서 제공하는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 가지므로, 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 활용할 수 있다.
Description
본 발명은 항생제에 대한 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균시키는 박테리오파지에 관한 것이다.
클렙시엘라(Klebsiella)속 균에 해당하는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)는 그람 음성의 피막을 가진 혐기성 세균으로 입, 피부, 장 등의 정상세균총에서 발견된다. 병원 밖 클렙시엘라 세균에 의해 유발되는 가장 흔한 감염질환은 폐렴이 있으며, 전형적으로 기관지폐렴 및 기관지염의 형태로 나타난다. 크렙시엘라 뉴모니아는 감염 및 출혈을 통해 인간 폐를 파괴할 수 있고, 때로는 점액성 객담을 생성하기도 한다. 상기 세균은 전형적으로 구강 인두에 대량으로 서식하는 미생물 흡입에 의해 기도로 들어가 감염을 유발하는 것으로 알려져 있다.
상기 클렙시엘라속 균의 감음은 대부분 면역력이 약한 사람에게서 두드러지게 나타나며, 항균 치료를 수행하더라도 약 50%의 높은 사망률을 나타내고 있다. 특히, 클렙시엘라 뉴모니아는 구강 등의 흡입 이외에도 비뇨기관, 쓸개관, 및 수술에 의한 상처부위에서도 감염을 유발할 수 있다. 최근, 클렙시엘라 뉴모니아가 병원 내 감염에 있어서 매우 중요한 병원균으로 인식되고 있다.
항생제 오남용 및 이로 인한 내성균 출현 등으로 대표되는 기존 합성 항생제의 문제점이 세계적으로 크게 이슈화되어 있는 상황에서 이에 대한 해결책을 제시해 줄 수 있는 대상으로 주목을 받고 있는 것이 바로 박테리오파지(Bacteriophage) 및 박테리오파지 유래의 리신(Lysin) 단백질이다. 박테리오파지 및 리신 단백질은 기존 항생 물질과는 완전히 다른 계열이라 할 수 있으며 이에 따라 전혀 다른 항균(antibacterial) 작용 기작(mode of action)을 갖고 있다. 따라서 기존 항생제의 사용에서 나타나던 여러 부작용(side effect)이나 문제점을 개선할 수 있을 것으로 기대를 모으고 있다.
박테리오파지는 박테리아를 감염시킬 수 있으며 보통 파지(phage)라고 줄여서 부르기도 한다. 박테리오파지는 핵산으로 이루어진 유전물질 중심부를 단백질 외피가 싸고 있는 단순한 구조의 유기체이며, 핵산은 단일 사슬이거나 이중 사슬인 DNA 또는 RNA로 되어있다. 박테리오파지는 생존에 숙주(host)가 반드시 필요하며, 모든 박테리아에는 특정 박테리오파지가 존재한다고 알려져 있다. 박테리오파지는 박테리아의 세포벽(cell wall)의 펩티도글리칸(peptidoglycan) 층(layer)을 공격하여 세포벽을 파괴함으로써 박테리아를 사멸시킬 수 있다. 박테리오파지는 1915년 영국의 세균학자 Twort와 1917년 프랑스의 dHerelle에 의해 독립적으로 규명되었으며 세균을 잡아먹는다는 뜻에서 박테리오파지라고 명명되었다. 박테리오파지의 항박테리아 활성(antibacterial activity) 때문에 발견 직후부터 인체와 동물의 질병 치료에 사용되었다. 그러나 Flemming에 의해 페니실린이 발견된 이후, 계속된 다양한 항생제의 등장 및 보급화로 인하여 서구에서는 관심이 점차 줄어들게 되었다. 그러나 러시아와 독일 등의 동구권 나라들은 박테리오파지 연구를 계속 해왔으며 관련하여 다수의 제품들이 산업화된 바도 있다. 하지만, 2000년대에 이르러 항생제 내성균 문제가 부각되면서 서구에서도 다시 박테리오파지에 대하여 관심을 갖게 되었으며 그 후 약 7~8년이 흐른 최근, 산업화 사례들이 속속 보고되고 있다. 즉, 박테리오파지가 세계적으로 새롭게 재조명되기 시작한 시기는 2000년대 초반으로, 실질적 산업화 노력이 약 7 ~ 8 여년 정도 진행된 신규한 분야로서, 생명공학기술의 발전과 맞물려 최근 매우 활발히 관련 개발이 진행되고 있는 분야라 할 수 있다.
박테리오파지의 가장 큰 특징으로는, 감염성 박테리아 속에 침투한 다음 박테리아의 세포벽을 파괴하여 박테리아의 사멸을 유도한다는 것이며, 이러한 박테리오파지에 의한 세포 사멸의 기작은 세균의 세포벽 합성을 방해하는 방식의 기존 합성 항생제의 기작과는 완전히 다르다. 따라서 기존 합성 항생제에 대한 감수성에 관계없이 자신의 항균 활성을 발휘할 수 있다. 이로 인하여 특히 기존 항생제에 대하여 이미 내성을 획득한 내성균에 대해서도 항균 효과가 있다. 또한, 박테리아에 대해서는 매우 특이적인 항균 활성을 가지고 있기 때문에 인간을 포함한 동물을 구성하는 세포인 진핵세포(eukaryotic cell)에는 영향을 주지 않는다는 장점을 갖고 있다.
본 발명의 일 목적은 항생제 내성 클렙시엘라속 균에 대하여 특이적인 감염 및 세포 사멸 능력을 갖는 신규한 박테리오파지를 제공하는 것이다.
본 발명의 다른 목적은 클렙시엘라속 균에 대하여 특이적인 세포 사멸 능력을 갖는 신규한 박테리오파지를 유효성분으로 포함하여, 상기 클렙시엘라속 균에 의해 유발되는 질환의 예방 또는 치료용 약학 조성물 및 개선용 식품 조성물을 제공하는 것이다.
본 발명의 또 다른 목적은 본 발명에 따른 상기 박테리오파지를 포함하는 항생제 및 소독제를 제공하는 것이다.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업계에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.
본 발명의 발명자들은 항생제 내성 세균 감염증 치료의 대안 물질로 기존의 화학 용법 제제를 보완할 수 있는 박테리오파지를 검토하던 중 항생제 내성 클렙시엘라(Klebsiella)속 균을 선택적으로 사멸시킬 수 있는 박테리오파지를 분리하고, 분리된 박테리오파지의 형태적 및 유전적 특성을 분석하여 이를 타 박테리오파지와 구별하여 특정 지을 수 있는 유전체(genome)의 유전자 서열을 제공하며, 더 나아가 항생제 내성 클렙시엘라속 균에 특이적 사멸능을 갖는 분리된 박테리오파지를 이용하여 상기 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 이용함으로써 본 발명을 완성하였다.
구체적으로, 본 발명자들은 항생제 내성 클렙시엘라속 균에 대하여 선택적으로 사멸시키기 위해 노력한 결과, 병원체로부터 카바페넴 내성을 갖는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)를 분리하였고, 상기 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 신규한 박테리오파지를 선별하여 이를 "YMC16/01/N133_KPN_BP"로 명명하였다. 이렇게 선별된 상기 박테리오파지를 2017년 5월 17일자로 한국생명공학연구원 미생물자원센터(기탁번호: [KCTC18575P])에 기탁하였다.
본 발명의 일 구현 예는 항생제 내성 클렙시엘라(Klebsiella)속 균에 대하여 특이적인 세포 사멸능을 갖고, 서열번호 2 내지 4 중 어느 하나로 표시되는 유전체를 포함하는 박테리오파지일 수 있다.
본 발명에서 상기 클렙시엘라(Klebsiella)속 균은 장내세균과의 한 속으로, 협막을 지니며 점액을 생산하고, 탄소원으로서 구연산염을 이용하는 균으로, 자연계에 널리 존재하며 사람의 호흡기, 장관 및 비뇨기에서 검출된다. 일반적으로 상기 균은 비병원성이지만 다양한 질병의 2차 감염과 폐렴 등의 질환의 원인이 될 수 있다.
본 발명에서, 상기 클렙시엘라속 균은 클렙시엘라 뉴모니아(Klebsiella pneumoniae), 클렙시엘라 옥시토카(Klebsiella oxytoca), 클렙시엘라 플란티콜라(Klebsiella planticola) 및 클렙시엘라 테리게나(Klebsiella terrigena)로 구성된 군으로부터 선택되는 어느 한종일 수 있으며, 바람직하게는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)일 수 있으나, 이에 제한되는 것은 아니다.
단, 본 발명에서 상기 클렙시엘라 뉴모니아(Klebsiella pneumoniae)는 간균으로도 불리우며, 아종으로 뉴모니아(Pneumoniae), 아자니아(azaenae) 및 리노스틸레로마티스(rhinoscleromatis)가 존재하며, 상기 균은 급성폐렴, 취비증, 비경종증을 유발할 수 있다. 또한, 항생 물질에 내성이 존재하고, 건조하지 않는 경우 실온에서 수개월 동안 생존할 수 있다.
본 발명에서 상기 "항생제 내성"은 특정 항생제에 내성을 보여 약효가 듣지 않는 것을 의미하며, 본 발명의 목적상 상기 항생제는 카바페넴(Carbapenem)의 구조를 갖는 항생제일 수 있다. 구체적으로, 아미카신(Amicacin), 앰피실린(Ampicillin), 엠피실린/설벡탐(Ampicillin/Sulbactam), 아즈트레오남(Aztreonam), 세즈타지딤(Ceftazidime), 세파졸린(Cefazolin), 에르타페넴(Ertapenem), 세페핌(Cefepime), 세폭시틴(Cefoxitin), 세포탁심(Cefotaxime), 젠타마이신(Gentamicine), 레보플록세신(Levoflocacin), 메로페넴(Meropenem), 피페라실린/타조박탐(Piperacillin/Tazobactam), 코트리목사(Cortrimoxa), 및 티게틸린(Tigecyline)으로 구성된 군으로부터 선택되는 어느 하나일 수 있으나, 이에 제한되는 것은 아니다. 본 발명의 목적상 상기 클렙시엘라 뉴모니아는 항생제 내성을 갖는 것일 수 있고, 상기 항생제 내성은 상기 카바페넴을 분해하여 효과의 발휘를 억제하는 카바페넴아제 효소(carbapenemase)를 생산함으로써 발생 될 수 있다.
또한, 본 발명에서 상기 “박테리오파지”는 세균을 숙주 세포로 하는 바이러스 일군의 총칭으로, 숙주에 감염된 후 증식하여 자손 파지를 방출하는 용균성을 갖는 회로 또는 숙주 염색체와 공존한 상태에서 숙주는 생존하고, 파지 DNA는 복제하는 회로를 갖는다. 본 발명의 목적상 상기 박테리오파지는 전체 게놈 크기가 58387bp의 서열번호 1로 표시되는 유전체로 이루어진 것일 수 있고, 서열번호 2 내지 4 중 어느 하나로 표시되는 유전체를 포함하는 것일 수 있다. 구체적으로, 상기 서열번호 2 내지 4는 상기 박테리오파지의 ORF(Open reading frame)로, 상기 클렙시엘라속 균에 흡착 및 용균의 기능을 수행하는 단백질을 코딩하는 유전체일 수 있으며, 보다 상세하게는 상기 서열번호 2는 ORF9로 파지 리소자임(phage lysozyme)을 코딩하는 유전체의 염기 서열이고, 서열번호 3은 ORF39로 홀린을 코딩하는 유전체의 염기 서열이며, 서열번호 4는 ORF40으로 홀린을 코딩하는 유전체의 염기 서열이다.
또한, 본 발명에서 상기 박테리오파지는 시포비리데(siphoviridae)에 속하는 박테리오파지일 수 있다.
단, 본 발명에서 상기 “시포비리데(siphoviridae)”는 박테리오파지를 전자현미경을 통한 형태 관찰에 의해 분류 및 동정하는 방법에 의해 분류된 것으로, 수축성이 없는 수축성이 없는 긴 꼬리(a long non-contractile tail)를 갖는 복합형의 형태를 나타낸 것일 수 있다.
본 발명의 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC16/01/N133_KPN_BP를 유효성분으로 포함하는 항생제 내성 클렙시엘라속 균 유발성 질환의 예방 또는 치료용 약학 조성물을 제공한다.
본 발명의 약학 조성물은 1 × 103 내지 1 × 1010 pfu/㎖의 박테리오파지를 포함하며, 바람직하게는 1 × 106 내지 1 × 109 pfu/㎖의 박테리오파지를 포함할 수 있다.
본 발명의 약학 조성물에 포함되는 박테리오파지 YMC16/01/N133_KPN_BP는 상술한 바와 같이, 항생제 내성 클렙시엘라속 균, 바람직하게는 카바페넴 내성 클렙시엘라속, 보다 바람직하게는 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 용균능 및 흡착능이 존재하므로, 본 발명의 약학 조성물을 사용하는 경우 상기 항생제 내성 클렙시엘라속 균을 용균 및 사멸시켜 인체 내에서 상기 항생제 내성 클렙시엘라 속 균의 감염으로 인하여 유발되는 다양한 질환을 효과적으로 예방 또는 치료할 수 있다.
본 발명의 약학 조성물에서 상기 클렙시엘라속, 유전체, 박테리오파지, 항생제 내성, 시포비리데, 기탁번호, 및 클렙시엘라 뉴모니아에 대한 내용은 상기 박테리오파지에서 기재한 바와 중복되어, 이하 구체적인 기재를 생략한다.
본 발명에서 상기 클렙시엘라속 균 유발성 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군에서 선택되는 어느 하나인 것일 수 있다. 본 발명의 목적상 상기 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군으로부터 선택되는 어느 하나일 수 있으나, 이에 제한되는 것은 아니다.
본 발명에서 상기 "치료"는 (ⅰ) 클렙시엘라속 균 에 의해 유발된 질환의 예방; (ⅱ) 클렙시엘라속 균에 의해 유발된 질환의 억제; 및 (ⅲ) 클렙시엘라속 균 에 의해 유발된 질환의 경감을 의미한다.
본 발명에서 상기 약학 조성물은 캡슐, 정제, 과립, 주사제, 연고제, 분말 또는 음료 형태임을 특징으로 할 수 있으며, 상기 약학 조성물은 인간을 대상으로 하는 것을 특징으로 할 수 있다.
본 발명에서 상기 약학 조성물은 이들로 한정되는 것은 아니지만, 각각 통상의 방법에 따라 산제, 과립제, 캡슐, 정제, 수성 현탁액 등의 경구형 제형, 외용제, 좌제 및 멸균 주사 용액의 형태로 제형화하여 사용될 수 있다. 본 발명의 약학 조성물은 약학적으로 허용 가능한 담체를 포함할 수 있다. 약학적으로 허용되는 담체는 경구 투여 시에는 결합제, 활탁제, 붕해제, 부형제, 가용화제, 분산제, 안정화제, 현탁화제, 색소, 향료 등을 사용할 수 있으며, 주사제의 경우에는 완충제, 보존제, 무통화제, 가용화제, 등장제, 안정화제 등을 혼합하여 사용할 수 있으며, 국소투여용의 경우에는 기제, 부형제, 윤활제, 보존제 등을 사용할 수 있다. 본 발명의 약학 조성물의 제형은 상술한 바와 같은 약제학적으로 허용되는 담체와 혼합하여 다양하게 제조될 수 있다. 예를 들어, 경구 투여시에는 정제, 트로키, 캡슐, 엘릭서(elixir), 서스펜션, 시럽, 웨이퍼 등의 형태로 제조할 수 있으며, 주사제의 경우에는 단위 투약 앰플 또는 다수회 투약 형태로 제조할 수 있다. 기타, 용액, 현탁액, 정제, 캡슐, 서방형 제제 등으로 제형화할 수 있다.
한편, 제제화에 적합한 담체, 부형제 및 희석제의 예로는, 락토즈, 덱스트로즈, 수크로즈, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말디톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로즈, 폴리비닐피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 또는 광물유 등이 사용될 수 있다. 또한, 충진제, 항 응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 포함할 수 있다.
본 발명에 상기 약학 조성물의 투여 경로는 이들로 한정되는 것은 아니지만 구강, 정맥내, 근육내, 동맥내, 골수내, 경막내, 심장내, 경피, 피하, 복강내, 비강내, 장관, 국소, 설하 또는 직장이 포함된다. 경구 또는 비경구 투하가 바람직하다.
본 발명에서 상기 "비경구"란, 피하, 피내, 정맥내, 근육내, 관절내, 활액낭내, 흉골내, 경막내, 병소내 및 두개골내 주사 또는 주입기술을 포함한다. 본 발명의 약학 조성물은 또한 직장 투여를 위한 좌제의 형태로 투여될 수 있다.
본 발명의 상기 약학 조성물은 사용된 특정 화합물의 활성, 연령, 체중, 일반적인 건강, 성별, 정식, 투여 시간, 투여 경로, 배출율, 약물 배합 및 예방 또는 치료될 특정 질환의 중증을 포함한 여러 요인에 따라 다양하게 변할 수 있고, 상기 약학 조성물의 투여량은 환자의 상태, 체중, 질병의 정도, 약무 형태, 투여 경로 및 기간에 따라 다르지만 당업자에 의해 적절하게 선택될 수 있고, 1일 0.0001 내지 50mg/kg 또는 0.001 내지 50mg/kg으로 투여할 수 있다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. 본 발명에 따른 의약 조성물은 환제, 당의정, 캡슐, 액제, 겔, 시럽, 슬러리, 현탁제로 제형화될 수 있다.
본 발명의 또 다른 구현 예에 따르면, 본 발명에 따른 박테리오파지 YMC16/01/N133_KPN_BP를 유효성분으로 포함하는 항생제 내성 클렙시엘라속 균 유발성 질환의 예방 또는 개선용 식품 조성물을 제공한다.
본 발명의 식품 조성물은 1 × 103 내지 1 × 1010 pfu/㎖의 박테리오파지를 포함하며, 바람직하게는 1 × 106 내지 1 × 109 pfu/㎖의 박테리오파지를 포함할 수 있다.
본 발명의 식품 조성물에 포함되는 박테리오파지 YMC16/01/N133_KPN_BP는 상술한 바와 같이, 항생제 내성 클렙시엘라속 균, 바람직하게는 카바페넴 내성 클렙시엘라속, 보다 바람직하게는 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 용균능 및 흡착능이 존재하므로, 본 발명의 약학 조성물을 사용하는 경우 상기 항생제 내성 클렙시엘라속 균을 용균 및 사멸시켜 인체 내에서 상기 항생제 내성 클렙시엘라 속 균의 감염으로 인하여 유발되는 다양한 질환을 효과적으로 예방 또는 개선할 수 있다.
본 발명에서 상기 클렙시엘라속 균 유발성 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군에서 선택되는 어느 하나인 것일 수 있으나, 이에 제한되는 것은 아니다.
본 발명의 식품 조성물에서 상기 클렙시엘라속, 유전체, 박테리오파지, 항생제 내성, 시포비리데, 기탁번호, 클렙시엘라 뉴모니아, 클렙시엘라속 유발성 질환 및 예방에 대한 내용은 상기 박테리오파지에서 기재한 바와 중복되어, 이하 구체적인 기재를 생략한다.
한편, 본 발명에서, “개선”은 본 발명의 식품 조성물을 이용하여 클렙시엘라속 균의 감염으로 인해 발생한 증상이 호전 또는 이롭게 변경되는 모든 행위라면 제한없이 포함할 수 있다.
본 발명의 상기 화합물을 유효성분으로 포함하는 식품 조성물은 각종 식품류, 예를 들어, 음료, 껌, 차, 비타민 복합제, 분말, 과립, 정제, 캡슐, 과자, 떡, 빵 등의 형태로 제조될 수 있다.
본 발명에서 상기 화합물이 식품 조성물에 포함될 때 그 양은 전체 중량의 0.1 내지 50%의 비율로 첨가할 수 있으나, 이에 제한되는 것은 아니다.
본 발명에서 상기 식품 조성물이 음료 형태로 제조되는 경우 지시된 비율로 상기 식품 조성물을 포함하는 것 외에 특별한 제한점은 없으며, 통상의 음료와 같이 다양한 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 구체적으로, 천연 탄수화물로서 포도당 등의 모노사카라이드, 과당 등의 디사카라이드, 슈크로스 등의 및 폴리사카라이드, 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜 등을 포함할 수 있다. 상기 향미제로서는 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등) 등일 수 있다.
본 발명에서, 그 외 본 발명의 상기 식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 포함할 수 있다.
본 발명에서 상기 성분은 독립적 또는 조합하여 사용할 수 있다. 상기 첨가제의 비율은 본 발명의 핵심적인 요소에 해당하지 아니하지만, 본 발명의 식품 조성물 100 중량부 당 0.1 내지 약 50 중량부의 범위에서 선택될 수 있으나, 이에 제한되는 것은 아니다.
본 발명의 또 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC16/01/N133_KPN_BP를 유효성분으로 포함하는 항생제를 제공한다.
본 발명에서 상기 항생제는, 대부분의 다른 항생 물질들은 대상체인 균주의 내성이 증가함에 따라 갈수록 사용범위가 줄어들 수 밖에 없는데에 반하여, 본 발명의 상기 항생제는 상기와 같은 문제점과 무관하게 사용될 수 있으므로 항생제로 사용될 수 있는 수명이 길어질 수 있다.
단, 본 발명에서 상기 "항생제"는 방부제, 살균제 및 항균제를 총칭하는 의미를 나타낸다.
본 발명의 또 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC16/01/N133_KPN_BP를 유효성분으로 포함하는 소독제를 제공한다.
본 발명에서 상기 소독제는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 갖는 박테리오파지를 유효성분으로 하고 있으므로, 병원에서의 감염을 방지하기 위한 병원 및 보건용 도구 등의 소독제로 유용하게 사용될 수 있고, 일반 생활 소독제, 식품 및 조리 장소 및 설비의 소독제, 축산산업의 축사 소독제로 유용하게 사용될 수 있다.
도 1은 본 발명의 일 실시예에 따른 박테리오파지의 전자 현미경 사진을 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 흡창능을 그래프로 나타낸 것이다.
도 3은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 1단 증식 곡선을 나타낸 것이다.
도 4는 본 발명의 일 실시예에 따른 생체 외에서 박테리오파지의 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균능을 그래프로 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 pH 안정성을 그래프로 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 온도 안정성을 그래프로 나타낸 것이다.
도 7은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 전체 유전체 서열분석 결과를 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 흡창능을 그래프로 나타낸 것이다.
도 3은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 1단 증식 곡선을 나타낸 것이다.
도 4는 본 발명의 일 실시예에 따른 생체 외에서 박테리오파지의 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균능을 그래프로 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 pH 안정성을 그래프로 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 온도 안정성을 그래프로 나타낸 것이다.
도 7은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 전체 유전체 서열분석 결과를 나타낸 것이다.
이하, 본 발명을 하기의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다.
실시예
[실시예 1] 임상검체 분리 및 항생제 내성 균주 선별
세브란스 병원 환자들로부터 환자의 분변 내 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 균을 배양하여 분리하였다. 그 뒤, 감수성 결과는 Clinical and Laboratory Standards Institute (CLSI, 2009)를 기준으로 판독하였다. 감수성 시험은 뮬러-힌튼(Mueller-Hinton) 아가를 사용하여 외기 37에서 하룻밤 동안 배양하는 CLSI 디스크 확산 시험방법을 사용하였다. 클렙시엘라 뉴모니아 균에 대한 시험 항생제는 아미카신(Amicacin), 앰피실린(Ampicillin), 엠피실린/설벡탐(Ampicillin/Sulbactam), 아즈트레오남(Aztreonam), 세즈타지딤(Ceftazidime), 세파졸린(Cefazolin), 에르타페넴(Ertapenem), 세페핌(Cefepime), 세폭시틴(Cefoxitin), 세포탁심(Cefotaxime), 젠타마이신(Gentamicine), 레보플록세신(Levoflocacin), 메로페넴(Meropenem), 피페라실린/타조박탐(Piperacillin/Tazobactam), 코트리목사(Cortrimoxa), 및 티게틸린(Tigecyline)을 사용하였다. 수집된 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 53개 주의 항생제 내성 프로파일은 하기 표 1에 나타내었다. 단, 하기 표 1에서 S, I 및 R은 항균제에 대한 감수성을 평가한 결과로, 'S'는 민감(Susceptible), 'I'는 중간(Intermediate), 'R'은 내성(Resistant)를 의미한다.
숙주 균주 | 아미카신 | 엠피실린 | 엠피실린/설벡탐 | 아즈트레오남 | 세즈타지딤 | 세파졸린 | 에르타페넴 | 세페핌 | 세폭시틴 | 세포탁심 | 젠타마이신 | 레보플록사신 | 메로페넴 | 피페라실린/타조박탐 | 코트리목사졸 | 티게틸린 |
YMC15/09/P488 | ≤2 (S) | ≥32 (R) | ≥8 (R) | ≥16 (R) | ||||||||||||
YMC15/09/P546 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/09/U2874 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥16 (R) | 40 (S) | ≥8 (R) |
YMC15/09/N45 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/09/P756 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | 40 (S) | ≥8 (R) |
YMC15/09/N55 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/09/T741 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | 10 (R) | ≥128 (R) | 40 (S) | ≥8 (R) |
YMC15/09/U4318 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | 40 (S) | ≥8 (R) |
YMC15/09/P860 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/09/C1052 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/10/N12 | 6 (R) | ≥16 (R) | ||||||||||||||
YMC15/10/U1383 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | 40 (S) | ≥8 (R) |
YMC15/10/P776 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/10/N150 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N1073 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/G57 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | 25 (S) | 2 (S) | ≥64 (R) | ≥64 (R) | ≤1 (S) | 4 (I) | ≥16 (R) | ≥128 (R) | ≤20 (S) | ≤0.5 (S) |
YMC15/11/B4059 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/U2284 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N45 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N53 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N54 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | =8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N96 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N98 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N101 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N107 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N115 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N137 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/11/R3218 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N154 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/R3705 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/G223 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/12/P746 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | 40 (S) | ≥8 (R) |
YMC15/12/C910 | ||||||||||||||||
YMC16/01/R859 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/01/N136 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N133 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/01/N141 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | 4 (I) |
YMC16/01/N164 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N233 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N359 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/R3917 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/R3958 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/02/B372 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/02/N11 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N162 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N394 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N393 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N499 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N726 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/03/N942 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/04/R1602 | ≤2 (S) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥32 (R) | 8 (I) | ≥8 (R) | ≥16 (R) | ≥128 (R) | |||||||
YMC16/05/N235 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/05/N151 | ≥8 (R) | ≥16 (R) |
상기 표 1에서 보는 바와 같이, 수집된 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 중 53개 주에서 항생제 내성을 가지며, 특히, 클렙시엘라 뉴모니아 YMC16/01/N133는 카바페넴 분해 효소인 bla KPC 유전자를 갖는 다재내성 균주임을 확인하였다.
[
실시예
2] 박테리오파지 검체 수집
2-1 파지 은행 구축을 위한 검체 수집
세브란스 병원의 하수 처리시설에서 최초 침전지 거친 후 부유물질 및 침사물이 제거된 원수를 확보하였다. 이는 화학 처리 시설 전 단계의 하수로 제한하였다. 수집한 시료에 1L 당 염화나트륨 58g을 첨가한 후 10,000g에서 10분간 원심 분리하여 220nm 밀리포어 필터로 여과하였다. 얻어진 여과액에 폴리에틸렌글리콜(PEG, 분자량 8000)을 10% W/V으로 첨가하고 4에서 12시간 동안 냉장 보관하였다. 12시간 냉장 보관된 여과액을 12,000g에서 20분간 원심 분리하여 침전물을 파지 희석 완충액 (SM 완충액)에 재부유한 뒤, 동일한 양의 클로로포름을 첨가하여 냉동 보관하였다. 이를 3회 반복하여 300mL의 박테리오파지 부유액을 채취하였다.
2-2
용균성
파지 선별 및
용균역가
측정
용균성 파지의 분리 정제는 스팟 테스트(Spot Test)법 (Mazzocco A et al. In Bacteriophages, Clokie and Kropinski AM, eds. Humana Press. 2009)으로 실행하였다. 확보된 균주를 맥콘키 한천배지에서 접종 후 외기 35에서 하룻밤 동안 배양하였다. 배양 후, 투명한 플라크 형성을 보고 파지에 감수성인 균주를 선별하였다. 감수성인 균주를 맥콘키 한천 배지에 접종하여 35에서 12시간 동안 배양하였다. 살린 1ml 튜브에 McFarland 0.5 탁도로 각 균주의 현탁액 제조하고 H 탑 아가 (3 ml), 감수성 박테리아 100ul 및 파지 용액 (각각 1ul, 10ul 및 50ul)을 섞어 LB 아가에 도포한 후, 35에서 12시간 동안 배양하였다. 플라크 관찰한 후에 파스퇴르 파이펫으로 플라크를 채취하여 SM 완충 용액에 희석하고, 다시 감수성인 균주 현탁액을 이용하여 3회 반복 정제하였다. 이렇게 얻어진 순수한 박테리오파지는 SM 완충 용액에 희석하고 다시 감수성인 균주 현탁액을 이용하여 3회 반복 정제하였다. 이렇게 얻어진 순수한 박테리오파지는 SM 완충 용액에 희석하여 보관하였다.
실시예 1에서 확인한 항생제 내성 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 53주 각각을 맥콘키 한천배지에서 접종하여 배양한 후, 상기 과정에 의해 정제된 박테리오파지 YMC16/01/N133_KPN_BP를 도말된 각각의 내성 균주에 5ul로 접종하여 플라그 형성을 확인하고, 역가 범위를 확인하여, 용균성을 하기 표 2에 나타내었다.
단, 상기 표 2에서 + 및 -는 수집된 균주에 대한 플라크 활성을 평가한 것으로, '+'는 투명한 플라크(clear plaque)를 의미하고, '-'는 용균이 일어나지 않은 것을 의미한다.
숙주 균주 | 용균 여부 | 숙주 균주 | 용균 여부 |
YMC15/09/P488 | + | YMC15/11/R3218 | + |
YMC15/09/P546 | + | YMC15/11/N154 | + |
YMC15/09/U2874 | + | YMC15/11/R3705 | + |
YMC15/09/N45 | + | YMC15/11/G223 | + |
YMC15/09/P756 | + | YMC15/12/P746 | + |
YMC15/09/N55 | + | YMC15/12/C910 | + |
YMC15/09/T741 | + | YMC16/01/R859 | + |
YMC15/09/U4318 | + | YMC16/01/N136 | + |
YMC15/09/P860 | + | YMC16/01/N133 | + |
YMC15/09/C1052 | + | YMC16/01/N141 | - |
YMC15/10/N12 | + | YMC16/01/N164 | - |
YMC15/10/U1383 | + | YMC16/01/N233 | - |
YMC15/10/P776 | + | YMC16/01/N359 | - |
YMC15/10/N150 | + | YMC16/01/R3917 | + |
YMC15/11/N1073 | + | YMC16/01/R3958 | - |
YMC15/11/G57 | + | YMC16/02/B372 | + |
YMC15/11/B4059 | + | YMC16/02/N11 | - |
YMC15/11/U2284 | + | YMC16/02/N162 | - |
YMC15/11/N45 | + | YMC16/02/N394 | - |
YMC15/11/N53 | + | YMC16/02/N393 | - |
YMC15/11/N54 | + | YMC16/02/N499 | - |
YMC15/11/N96 | + | YMC16/02/N726 | - |
YMC15/11/N98 | + | YMC16/03/N942 | - |
YMC15/11/N101 | + | YMC16/04/R1602 | + |
YMC15/11/N107 | + | YMC16/05/N235 | + |
YMC15/11/N115 | + | YMC16/05/N151 | + |
YMC15/11/N137 | + |
상기 표 2에서 보는 바와 같이, 박테리오파지 YMC16/01/N133_KPN_BP는 항생제 내성 클렙시엘라 뉴모니아 53주 중 41주(77%)를 용균 시키는 것을 확인할 수 있었다.
[
실시예
3] 항생제 내성
클렙시엘라
뉴모니아균에
대한
용균성
박테리오파지의 전자 현미경 분석
상기 실시예 2의 방법에 의해 정제된 박테리오파지를 감수성 균주 배양 배지(20ml LB 배지)에 접종 및 배양한 뒤 220nm 밀리포어 필터로 여과하고, 상청액에 폴리에틸렌글리콜(MW 8,000)을 10%(w/v)의 양으로 첨가한 후 밤새 냉장 보관하였다. 이후 12,000g의 조건으로 20분 동안 원심 분리한 뒤, 에너지 여과 투과 전자현미경(Energy-Filtering Transmission Electron Microscope)을 이용하여 박테리오파지의 형태를 분석하여, 그 결과를 도 1에 나타내었다.
도 1에서 보는 바와 같이, 본 발명에 따른 상기 YMC16/01/N133_KPN_BP 박테리오파지를 모양으로 분류하는 기준으로 보았을 때, 파지가 수축성이 없는 긴 꼬리(a long non-contractile tail)를 갖고, 시스(sheath)가 없으므로 시포비리대(Siphoviridae)에 속하는 것으로 분류하였다.
[
실시예
4]
박페리오파지의
흡착능
및 1단 증식 곡선(One-step growth curve) 분석
항생제 내성을 갖는 클렙시엘라 뉴모니아균을 OD 값이 0.5가 되도록 배양한 뒤, 클렙시엘라 뉴모니아균에 상기 실시예 2에서 정제된 박테리오파지 YMC16/01/N133_KPN_BP를 MOI 0.001로 넣고 상온에서 배양한 뒤, 100ul 시료를 1, 2, 3, 4, 5분에 1ml씩 채취하여 LB 배지에 희석한 뒤 플라그 분석을 통해 상기 박테리오파지의 흡착능을 평가하여, 그 결과를 도 2에 나타내었다.
또한, 항생제 내성을 갖는 클렙시엘라 뉴모니아균을 OD 값이 0.3이 되도록 배양한 뒤, 4℃에서 5분 동안 7,000g로 원심 분리하여 세포를 침전시킨 후, 0.5ml의 LB 배지에 희석시키고, 상기 실시예 2에서 정제된 박테리오파지를 MOI 0.001(titer 108pfu/cells)를 넣고 37에서 5분 동안 배양하였다. 배양된 혼합 시료를 13,000g에서 1분 동안 원심 분리하여 얻어진 펠렛을 10ml의 LB 배지에 희석시키고 37에서 배양하였다. 배양 도중 10분 마다 시료를 채취하여 플라그 분석을 통해 상기 박테리오파지의 1단 증식 곡선을 평가하여, 그 결과를 도 3에 나타내었다.
도 2에서 보는 바와 같이, 상기 YMC16/01/N133_KPN_BP 박테리오파지의 접종 후 5분 이내에 박테리오파지의 68% 정도가 클렙시엘라 뉴모니아균에 흡착하였다.
또한, 도 3에서 보는 바와 같이, 1단 증식 곡선 결과 17PFU/감염 세포의 높은 버스트 사이즈를 나타내었다.
상기 결과를 통해 본 발명에 따른 상기 YMC16/01/N133_KPN_BP 박테리오파지는 항생제 내성을 갖는 클렙시엘라 뉴모니아균에 비교적 빠른 시간 내에 흡착할 수 있고, 높은 버스트 사이즈를 나타내 항생제 내성 균주의 용균 효과를 발휘하는 것을 알 수 있다.
[
실시예
5] 생체 외 항생제 내성
클렙시엘라
속 균에 대한 박테리오파지의 용균능 검증
항생제 내성 클렙시엘라 뉴모니아균 1 X 109 CFU/ml에 준비된 박테리오파지 YMC16/01/N133_KPN_BP를 1 X 108 CFU/ml(MOI: 0.1), 1 X 109 PFU/ml(MOI: 1), 1 X 1010 PFU/ml(MOI: 10)의 양으로 각각 처리하고 시간 별로 OD 값(파장 600nm)을 측정하였다. 단, 음성 대조군으로는 PBS+SM 버퍼를 처리하여, 그 값을 도 4에 나타내었다.
도 4에서 보는 바와 같이, 음성 대조군과 비교할 때, 클렙시엘라 뉴모니아균에 대하여 박테리오파지를 처리한 경우 OD 값이 감소하였고, MOI 값이 증가할수록 OD 값은 더욱 감소하였다.
상기 결과를 통해, 본 발명에 따른 박테리오파지는 항생제 내성 클렙시엘라 뉴모니아균에 대하여 용균성을 갖는 것을 알 수 있다.
[
실시예
6] 항생제 내성
클렙시엘라
속 균에 대한 박테리오파지의 안정성 평가
본 발명에 따른 YMC16/01/N133_KPN_BP 박테리오파지가 온도 및 알칼리에서 파괴되지 않고 안정성을 유지하는지 확인하였다.
상기 실시예 2의 방법에 의해 정제된 박테리오 파지 1 ㎕를 4, 5, 6, 7, 8, 9 및 10의 pH로 맞춘 SM 버퍼 40 ㎕에 넣은 뒤, 37℃에서 1시간 동안 배양한 뒤 항생제 내성 클렙시엘라 뉴모니아균과 함께 상기 실시예 4의 방법으로 플라크 분석을 실시하여 그 결과를 도 5에 나타내었다.
또한, 상기 박테리오파지 용액을 각각 40℃, 50℃, 60℃ 및 70℃에서 배양하는 1시간 동안 10분 단위로 각각의 샘플을 클렙시엘라 뉴모니아균과 함께 상기 실시예 4의 방법으로 플라크 분석을 실시하여 그 결과를 도 6에 나타내었다.
도 5에서 보는 바와 같이, 본 발명에 따른 상기 파지는 pH 7에 해당하는 중성에서 가장 안정성을 나타내었고, 산성에 비해서는 알칼리에서 비교적 안정성을 나타내었다.
또한, 도 6에서 보는 바와 같이, 상기 파지는 40℃에서는 1시간 까지 약 70%의 PFU를 유지하였고, 50℃에서도 1시간에 약 50%의 PFU를 유지하였다.
[
실시예
7] 항생제 내성
클렙시엘라
속 균에 대한 박테리오파지의 전체 게놈 서열 분석
본 발명에 따른 상기 YMC16/01/N133_KPN_BP 박테리오파지의 특성을 규명하기 위하여 전체 유전자 서열 분석을 Illumina sequencer(Roche)를 통하여 통상의 기술자에게 자명한 전체 게놈 서열 분석 방법을 기초로 분석하여, 그 결과를 도 7 및 하기 표 3에 나타내었다.
유전체 번호 |
길이(bp) |
추정 기능 (Putative function) |
주석 출처 (Annotation source) |
E-value |
NCBI blastP identity (%) |
NCBI-Bank accession number |
ORF1 |
1286 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
6.00E-42 |
31% |
WP_032451636.1 |
ORF2 | |
hypothetical protein |
|
|
|
|
ORF3 |
605 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
6.00E-42 |
31% |
WP_032451636.1 |
ORF4 |
2189 |
phage-like DNA polymerase |
PHAGE_Roseob_1_NC_015466 |
2.00E-100 |
33% |
EGG92991.1 |
ORF5 |
266 |
hypothetical protein |
PHAGE_Pseudo_PaMx11_NC_028770 |
1.00E-14 |
43% |
YP_006561156.1 |
ORF6 |
1484 |
superfamily II DNA/RNA helicase |
PHAGE_Rueger_DSS3_P1_NC_025428 |
2.00E-119 |
43% |
YP_009099723.1 |
ORF7 |
665 |
HTH-domain containing protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
4.00E-16 |
32% |
YP_009099722.1 |
ORF8 |
215 |
excisionase |
PHAGE_Burkho_AH2_NC_018283 |
9.00E-05 |
40% |
YP_006561153.1 |
ORF9 |
647 |
putative endolysin |
PHAGE_Cronob_ENT47670_NC_019927 |
2.00E-46 |
44% |
YP_007237600.1 |
ORF10 |
140 |
ABC transporter permease |
|
1.3 |
57% |
WP_066292794.1 |
ORF11 |
881 |
putative phage methyltransferase protein |
PHAGE_Escher_K1_dep(4)_NC_027993 |
6.00E-51 |
44% |
CUV19063.1 |
ORF12 |
11 |
attL |
|
|
|
|
ORF13 |
1046 |
Phage integrase family protein |
PHAGE_Entero_mEp460_NC_019716 |
1.00E-99 |
45% |
SFD52906.1 |
ORF14 |
122 |
hypothetical protein |
|
|
|
|
ORF15 |
680 |
putative terminase small subunit |
PHAGE_Rueger_DSS3_P1_NC_025428 |
6.00E-27 |
40% |
YP_009099719.1 |
ORF16 |
2114 |
terminase large subunit |
PHAGE_Rueger_DSS3_P1_NC_025428 |
0 |
53% |
YP_009099718.1 |
ORF17 |
215 |
head-to-tail joining protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
4.00E-05 |
38% |
WP_064168520.1 |
ORF18 |
1673 |
phage portal protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
0 |
57% |
WP_035972152.1 |
ORF19 |
1295 |
signal peptide peptidase A |
PHAGE_Rueger_DSS3_P1_NC_025428 |
2.00E-88 |
46% |
YP_009099715.1 |
ORF20 |
419 |
putative head decorative protein |
PHAGE_Rhizob_vB_RleM_PPF1_NC_025427 |
6.00E-05 |
34% |
YP_009099570.1 |
ORF21 |
1040 |
putative major capsid protein |
PHAGE_Rhizob_vB_RleM_PPF1_NC_025427 |
7.00E-87 |
41% |
SFB80694.1 |
ORF22 |
272 |
hypothetical ABC transporter permease |
|
3.8 |
35% |
SCG77776.1 |
ORF23 |
407 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
2.00E-12 |
33% |
YP_007674925.1 |
ORF24 |
587 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
1.00E-37 |
40% |
YP_006561143.1 |
ORF25 |
494 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
1.00E-34 |
42% |
YP_009099709.1 |
ORF26 |
782 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
5.00E-55 |
41% |
YP_008239950.1 |
ORF27 |
458 |
tail protein |
PHAGE_Burkho_AH2_NC_018283 |
1.00E-07 |
34% |
YP_006561139.1 |
ORF28 |
125 |
hypothetical protein |
|
|
|
|
ORF29 |
143 |
hypothetical protein |
|
|
|
|
ORF30 |
4472 |
tail tape measure protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
3.00E-38 |
36% |
YP_009099705.1 |
ORF31 |
3527 |
hypothetical protein resolvase |
PHAGE_Rueger_DSS3_P1_NC_025428 |
1.00E-24 |
33% |
WP_006519218.1 |
ORF32 |
845 |
hypothetical protein resolvase |
PHAGE_Rueger_DSS3_P1_NC_025428 |
8.00E-23 |
31% |
WP_073550093.1 |
ORF33 |
224 |
hypothetical protein |
PHAGE_Rueger_DSS3_P1_NC_025428 |
2.00E-07 |
38% |
YP_009125172.1 |
ORF34 |
134 |
hypothetical protein |
|
|
|
|
ORF35 |
2267 |
Putative phage tail protein |
PHAGE_Pseudo_PaMx11_NC_028770 |
4.00E-74 |
30% |
SFK45015.1 |
ORF36 |
779 |
putative tail fiber protein |
PHAGE_Proteu_pPM_01_NC_028812 |
4.00E-12 |
38% |
YP_008239861.1 |
ORF37 |
3609 |
putative prophage endo-N-neuraminidase |
PHAGE_Klebsi_vB_KpnM_KB57_NC_028659 |
1.33E-06 |
84% |
SAT12392.1 |
ORF38 |
1094 |
hypothetical protein |
PHAGE_Vibrio_VHML_NC_004456 |
2.48E-51 |
99% |
WP_020805028.1 |
ORF39 |
425 |
putative holin |
PHAGE_Entero_mEp390_NC_019721 |
1.00E-10 |
37% |
WP_012004110.1 |
ORF40 |
338 |
putative holin |
PHAGE_Salmon_epsilon15_NC_004775 |
1.00E-16 |
42% |
YP_009287757.1 |
ORF41 |
125 |
hypothetical protein |
|
|
52% |
WP_021395675.1 |
ORF42 |
515 |
hypothetical protein |
PHAGE_Bacill_G_NC_023719 |
2.00E-20 |
34% |
SFP41882.1 |
ORF43 |
239 |
hypothetical protein |
|
|
|
|
ORF44 |
149 |
hypothetical protein |
|
|
|
|
ORF45 |
194 |
putative prophage endo-N-neuraminidase |
PHAGE_Salmon_vB_SenS_Ent2_NC_023608 |
6.92E-18 |
|
|
ORF46 |
275 |
hypothetical protein |
PHAGE_Entero_c_1_NC_019706 |
0.019 |
42% |
YP_007111534.1 |
ORF47 |
281 |
hypothetical protein |
|
|
|
|
ORF48 |
242 |
hypothetical protein |
|
|
|
|
ORF49 |
200 |
hypothetical ABC transporter permease |
|
0.066 |
45% |
YP_007005763.1 |
ORF50 |
320 |
hypothetical protein |
|
|
|
|
ORF51 |
332 |
hypothetical protein |
|
|
|
|
ORF52 |
224 |
hypothetical protein |
|
|
|
|
ORF53 |
1352 |
pyrophosphatase |
PHAGE_Burkho_AH2_NC_018283 |
|
|
|
ORF54 |
167 |
hypothetical protein |
|
|
|
|
ORF55 |
461 |
putative phosphatase |
PHAGE_Escher_ECBP5_NC_027330 |
1.00E-42 |
66% |
CAR57480.1 |
ORF56 |
338 |
hypothetical protein |
|
|
|
|
ORF57 |
578 |
hypothetical protein |
PHAGE_Bordet_BPP_1_NC_005357 |
1.00E-07 |
45% |
ANS05651.1 |
ORF58 |
341 |
hypothetical protein |
PHAGE_Erwini_vB_EamP_S6_NC_019514 |
2.00E-16 |
45% |
AIK67555.1 |
ORF59 |
113 |
hypothetical protein |
|
|
|
|
ORF60 |
194 |
hypothetical protein |
|
|
|
|
ORF61 |
1067 |
hypothetical protein |
PHAGE_Entero_P1_NC_005856 |
1.13E-27 |
45% |
EFW38123.1 |
ORF62 |
11 |
attR |
|
|
|
도 7 및 상기 표 3에서 보는 바와 같이, 상기 박테리오파지의 전체 유전자는 58387bp/ GC:59.30%의 linear dsDNA로, 62개의 ORF로 구성되어 있었으며, 전체 ORF 중 30개의 유전자만이 기능 단백질을 코딩하고 있었고, 나머지는 가설 단백질(Hypothetical protein)을 코딩하는 유전자로 분석되었다. 또한, 본 발명의 상기 ORF 중 용원성 유전자(lysogenic gene) 또는 독성 관련 유전자(toxin related gene)은 존재하지 않았다.
또한, 본 발명에 따른 YMC16/01/N133_KPN_BP 박테리오파지가 용균 효과를 나타내는 단백질을 코딩하는 유전자의 서열은 ORF9, ORF39 및 ORF40에 해당하였다.
상기 ORF9은 라이소자임(lysoqyme)을 코딩하는 유전자로 녹농균 파지 SM1과 55%의 유사성을 보였으나, ORF39 및 ORF40은 기존의 박테리오파지의 서열과 대조한 결과, 본 발명에 따른 박테리오파지와 유사성을 갖는 박테리오파지는 검출되지 않았다.
상기 결과를 통해 본 발명에 따른 YMC16/01/N133_KPN_BP 박테리오파지는 기존에 발견되지 않은 신규한 박테리오파지에 해당함을 알 수 있다.
이상에서 본 발명에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고, 청구범위에 기재된 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 다양한 수정 및 변형이 가능하다는 것은 당 기술분야의 통상의 지식을 가진 자에게는 자명할 것이다.
<110> Industry-Academic Cooperation Foundation, Yonsei University
<120> LYTIC BACTERIOPHAGE SPECIFIC FOR KLEBSIELLA GENUS RESISTANT TO
ANTIBIOTICS
<130> DPB172713
<160> 4
<170> KoPatentIn 3.0
<210> 1
<211> 58387
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC16/01/N133_KPN_BP
<400> 1
atgatcgatg tcatcaaggg cattgaaacg catctggaag agaccggtca ggtcgacagc 60
gatgacgatg aaggcgatac cggtgagttc agcgatcgta ttcaggctct gatcgatgaa 120
gttccggaag agcctaccgc ggatgacatc actgacctgt tcaaaaagta tctgccgaaa 180
gaccttgaaa aggcagaacg tgacgcccgc gctgaaatca tcaagccgat tctggccggc 240
gtgaaagcgc cgaaggcttc tgccgtgaag gacgacgacc gccgcgacgt catgatcgat 300
gtcatcaagg gcattgaaac gcatctggaa gagaccggtc aggtcgacag cgatgacgac 360
gaaggcctgg tgtaaccagt agcttgtgct gacgggggtg gcgattgcca cccctttgct 420
ttgggaccaa cctgatgctg aaaacgatag acggaaagga aatcatagac ctcggatggg 480
gaggtgtgca ttccgagcgc agtccgtcgg ccgctgaccg gtggatgaca tgcccgggct 540
ccgtgcagct gagccgcctc tttgacgatg agacgagcat cttcgccgcg gagggcacct 600
gcgcccactg ggtacgcgag cagtgcctga atgaccggtc gaaaaatgtc gaggactacg 660
tcggtaccat catccacgcc gacggctatt attttgaagt gctaccagaa tgggtagggt 720
acctgcagcc tacgatcgac tgggcgcgtg atgtcagcag caaacgtggc tgcgagatgg 780
tggtcgagta tcgcgtagac ctgtcccgct ggcttcccgg cgactccggc actctcgatc 840
ttgggatcac cactcccgat atcatttaca tcaatgatga gaagttcgga cagggtgtgc 900
tggtggaggc cgagcgcaac cggcagcaga tgatttacgc tctcggcttc tggtggaacc 960
acgcgcgcca caagacaaag gccacgacct tccggctgat gatcgaccag cctcgcgccc 1020
gcggtggcgt cggcagctcg tgggattgta cgctggaaga gctgctggag ttcggcgaag 1080
aggtgcgcgt tgccggcgag ctgacgcgtg acccggatgc tccgctggtg gtgagcgcca 1140
aaggctgtca gttctgcaag gtcctgtcca atctggcgtg cccggctgtg cacgactttg 1200
tccaggaggc cgctggcctc aaccccgata taccaaaact caaggggcca cttatcatgc 1260
ctgaaattga aaaactggat atggaccgcc ggctttacct gctgaagaac tggtccatca 1320
tctcgaaata cggcagcctg ctgaagcaga acgtgctgtc tgatgccatg agcggcgagc 1380
ccacccccgg cttcaaagcc gtggctaccg aaggtgaccg catgtgggtc agcgaagaaa 1440
gtgtgatcga gttcttcaga gggaaaattc cggataagga tttattcaat aaacagttga 1500
aatctcctgc gcaagttgag aagatagccg gcacgcggac atggaaacaa gcgcaggagc 1560
ttatcgtccg ccctgaaggc ccaccagccc ttgttccgga atcggacaag cggccggcgc 1620
tgatgaatct cacggatctg ctggacgacc tggacagcga tgaggacgac ttctccgact 1680
taatcggaga ggacgacggg gatttagact ccctgattta acaccgtact actgaccaac 1740
gaaccgacta tcaacgtact actgaggaat gtaaaaatgg ctgaacaacg cttaggtacc 1800
tttgccatca ctggtcgtct gtccttcccg agaatctgga agaaagagaa gtccgcggaa 1860
gagggtaagc cgaaatactc gctgaacatc atcatggacc cggatacctc ttctggcgag 1920
aagagcatcg agacctgtga gagagagctg aaagctctgg ctaagcgcac ctggcaggac 1980
aaaggcccga aagtgctgaa agctctggac cgtaaacgca tcccgctgct ggatggtgac 2040
gagtgcacca acagcgaagg cgacgtttat cagggctatg aaggcatgaa gatcttcaaa 2100
tgcgccaacc cgcgcgaatt caagcgcctt gatcgtgata agtccatcct gaccgaagag 2160
acagctgatg agctgaatcg cctgtacggt ggctgctacg ttgacgcggt ggtgaacatc 2220
tacgccatca ccgataaagc gcgcggcggg aacggtattt tcgcttcgat cgaagtcctt 2280
cgccaccgca aagacggcga accgttcggt gcagcaccgg ttgacgagga tgattacctc 2340
gatgacctgg gtgacgacga agacgaagac gacctggttt aatccacgtc aaatttatca 2400
aggggcttcg gccccttttt caactgactg tggagcattc aatgtatggc tgcagaaaag 2460
atccatctcg actatgaatc ccggagcacg ctgccgttcg gcaaacaggg cggcgtgacc 2520
acctaccagt attcccgtca ccccacgacc gaaatccttc tcgccagtta taagattggc 2580
tcggacccca tcgagcgctg gcgccgtggg caacctcttc ctaagcggct ccgtgaggcg 2640
gtgggggatg gcctgaagct gtgtgcgcat aacttcgcgt tcgaatgggc catgtggaac 2700
aacatatggg tgccccgtct gggagcgccc gttttgccgt tctctcaagg ggactgtacc 2760
gcggtgcgcg cttccgtgct ggcgctgcct cgctcattgt ccgaagcctg taaagccctc 2820
ggcctgtctg tccgtaagga cgaggaaggc gcgaaggtga tgctgaagat ggcgaagccg 2880
cgtaaggccc gtaaggacga ggatccggac agcatctggt ggtgggacac ccctgaactg 2940
atggaccgcc tgcacgacta ctgcgacatc gacgtcgagg tggaatacgc gcttgatcag 3000
gtccttccag agcttaccga agacgagtgg cagctgtggc aaatggacca ccgcactaat 3060
cagcgcggcg tgctgctgga catgcccttt atccataagg cgaagcggct catggccgtg 3120
tcagagcgcc actacaataa cgagctttcg aagatcaccg gcggtgaagt caaggcggtc 3180
acagaggtag gacctctgcg aaactgggtg aacgataaca gcgagctggc gctaccgagt 3240
tttgataaga cccaggtcga aaatgcgttg aaagatcccg acgtcccgga tgacgttcgt 3300
cgcgttctgg agatccgcca ggaagccggc aagtcctcag tcgccaaata cacaaaattc 3360
gagctgctgg cctatcttga caacgtcatg cgggaaaact tcctgcatca tggggccaac 3420
accgggcgca gcgccggcaa aggtgcccag ctgcagaacc tgccgtcccg cggcgggttg 3480
aagtggtacc aggccgtcga agtgatcaag atggtcatgg agactgacga cccagaatgg 3540
gcgttccagc gcatagagat gatttatggc ggcgtgccag aagccctgtc gtcatgcctg 3600
cgcctgtgca tcatcgcgcg cccgggcaaa aagctgtacg tggctgactt ctcgaacatc 3660
gaggggcgcg tcgcggcatg gctcggcggt gagaagtgga agctggaagc attcaagctc 3720
tacgataccc ctctgctgga cgagcacggc cagaaaatcc cggatcccga caccgagttc 3780
aagcggaaag ggcctgacct gtacaaggtc accgccgcgc agatcctcgg cacgacgccg 3840
gacatcatca acaaggtgca gcgtaacgtc atgggtaagg tcccggagct ggcgctgggc 3900
tttggtggcg gcgtcggcgc cttccagtca atggcgaaga tctacaacgt caatatggcg 3960
gactactggg acatcgtccg gacgtcgctg gaccagcgct tcgtggacaa ggcgttcgat 4020
aactgggagt ccttcggcaa gaaatctggc atcccgcagg acgagtggct ggcttccgag 4080
accgtcaagc tggcgtggcg cgcccgccac cctggcattg tgcgctgctg gcgcgacgct 4140
gaagagtgcg cggtcaaggc gctgaagacc cccggcaaat ggttcaaatt cgccggcggc 4200
aaatgtgcct tcggggcgaa gaagatcggc gaaaagatgt tcctcatctc ccggcttccc 4260
aacggccgcc gcgtgtaccg ctgcgacgcc cacctgaaaa cggtgaagaa gttcggccgc 4320
atggtcgatg aaatccgctt catgggcgtg gacagcgtca cgaagcagtg ggtccgcatg 4380
agcacctacg gtggtgacct cttccagacc ttcgtgcagg cgatcgcacg cgacatcatg 4440
aaagacggga tggcgaacgt agaagccgct gacttcgacc cgatcctgga ggtccacgac 4500
gaggtgggct ctgaaggcga cgaagaccgc gacctccatg aatacgagaa cctgatggca 4560
acgctgaagc cttgctacga cgggtgcccg gtatccgcgc tcggctacgt cgccgaccgg 4620
taccgtaagg actgattatg ccgaaagttt ataataagca ttacccgggc gttccggatg 4680
acgcggtctg cattgagaga accacggagt ggggaaaccc attcccggtt cgcggtggcc 4740
gcacgcgaga ccaggctatc gacgcctttc gtgaatgggc gctgtccgat cccgattatg 4800
tccgcgccgt caaacgcgag ctgagcggca aggacctcgt ctgctgctgt aagccgaagc 4860
gctgtcacgg cgacgtcctg ctggagatcg ctaatgggtc ttgaatcaac gatcgaagat 4920
gtctgctgcg aggatgcgga ggctgacggg tggatggtca aaaagatcag cttccccggc 4980
agccgcggcg cactggaccg gatgttcatt aaaaatgggc gtgtcgtttt tatcgagttc 5040
aagcgtcccg ggaagctgaa aaataccagc accggccaga acgacaccat caaagacctt 5100
attgccgccg gcgccgagtg ccacgtcgtg gacactccgc tggccgtcta ccgtatttta 5160
gggattaaac gatgagcgga ttacgaccgc gttctgcgct ccgcaagagc cagcaggtcg 5220
cgtacaaaca gattatgggt gggccggcca cgatgctgtg gctggatatg ggctccggga 5280
aaaccggcac atcgctgacg gccattcgtg accttctgga ctggggctat gcagcccacg 5340
tgctggtcat cgcgccgctg ctggtagccg aagagacctg gccggacgaa attgagacgt 5400
gggagcacac cgtcgtcctc gattatgagg tgctgaccgg tgaccctgac cgccggtcca 5460
accgtgcgct gcgcctcccg gagctgagca ttatcaacgg ggagaacatc ccttggctgg 5520
tcgagttctg ggaagagcgc ggcgggtggc cctacgacgt cgtctttatc gatgagatct 5580
cgcgattcaa aaacccgacg aagcgcaaca agccgaccaa aaagcaggtg cgagatgtca 5640
ctgagcgcgt tctgaaggcg ctgccgcgcg gtaccactga ggaagatgcg gagaacgccc 5700
tgcgtaagga gctgaagaag ctgcgcggcg ggatcacccg cttcggtgcg ctgtgctccg 5760
tgctgccgta catcgatatc atggtgggcc tgacaggtac gcccggccca aatggcctga 5820
tcgacatctg ggctcagttc tatctgctgg accagggcca gcgtctcggc agcaacatca 5880
ccgcctataa gaagcgttgg ttcgacagcg attacatggg ctacaaatac gagccaaagc 5940
ctcatgcatt cggccaaatc gtggaggcca tccgcgacat cacggtcagc atcgagtcag 6000
acgccgagct acctccggtt gtatataaca ctctccgttg caagctgcct gcgagcgtca 6060
tgaagcagta tcagaaattt gagcggacat tgttgctgga agaacacgat gtcaaagccg 6120
tcaatgaagg ggtattaact ggcaaattat tgcagctggc gaatggttct gtttaccggg 6180
acaacgaagc cacaggtgag cgcgaagtta tcgagatcca ctcccggaag ctggaatatc 6240
tcgatcgcgt tatcgaagag gccaacggca aacccgtcat ggtggcgtac agctaccagt 6300
tcgacctgga taagctgaag aagaagtacc cgcacgcgga ggtcgtcggt gagacgaaga 6360
acctccagaa gcgctggaat gcgggggaaa tccagctgtt actggcgcat ccgcagtctg 6420
ccggtcacgg cctgaacctg caatacggtg gctgtattct cgtatggtat ggcctctgct 6480
ggtcgctgga atattaccag cagctgaaca agcgcctgca ccgcccgggg cagaaggaca 6540
ccgtgttcat ccaccatatc atctgcgagg gaacagtaga cgaaagggtg atgaaagttc 6600
tgcctgacaa agccgccacc caggacatgt taattcaggc cacgatgcgc aaatagagaa 6660
tcattccgcg acccgttgac acactcagaa tcactcggta gatgtgtcaa caatcagttg 6720
aatgaatccc agtttgtgga aaggtcacta agttgcgcga taaggcattt gcgcagcggc 6780
tcaataccgc ttgcgatggt caccctcata taccggccta cggacagggt cggcagacat 6840
gggtgaaaga gaagctggat gtgagccatg aggctgtccg gaaatggttc accggcgagt 6900
cccggcctcg tccggataag atgaagatgc tggcgcttaa cctggaggtg gatgaggcat 6960
ggctggcgct gggaattgcg ccggaccaga cgcctcgcga gaagaaggcg cgtgatgcta 7020
ccgctgaagg tgcggtgaat gtggtaacgg gcctgctgca gatgaatggt gctacctgcg 7080
cattcccggc cgagcaggat ccggcctctg ggtatgtcca tgtttacgcc attatgcgcg 7140
gtgtgcagct cgcaattcac gtcagcctgg cgaagaaact gggcgataat caatggaaat 7200
tcatcatccc taaagaatac gaacagtgcc gggtaattgg cgctattcac gtccgcccga 7260
acagactgca tctggtcagc atggatcatg acatgataga ccggtaccgc gtccgaaagg 7320
gcggattttt cgagattgtc gccagctacc atgatggaca ctactggtca ggtggcgaca 7380
aatggccccg tatagaatca tttgcaaggg atctgtgaca tggaatgtcc gtgggtcgcg 7440
ctacgcgacg tcgttcacct ctttggcatc acctacgaga ccgcgaagaa ccggatatac 7500
gccgagaact tcccggtccc ggtgcgtaag gaaggcaggc tgctggtggt ggataaagcg 7560
gtgctggaac gttattttga tgagaggcgt gctgaagatt tggcgcgtct ttcttcaacc 7620
cgtgaattca actaactggt gagaatgcaa ctatgactca ggatcagttc cgacgtgccg 7680
cgggtatcac tgacgcgctg gcgcagcagt ggtaccagcc catcaccgaa gcgatgcagc 7740
gcttccagat caacactccg aaacgtcagg ctgctttcct ggcgcagatc ggccacgaga 7800
gccgcggttt tacctgcgtg agcgagagcc tttactacaa agacccggag cgcatcgccc 7860
ggatcttcaa gtcaggcttc gacctcaata agaacggcaa ggtcgacctg gccgaggtag 7920
agttcgcgaa gggctatgtc cggaactctg tgaagctggc gaaccgggca tacgcgaatc 7980
gcctgggtaa cgggagcgaa gccagcggcg acgggtacaa attccgcggg cgcggcccga 8040
tgcagacgac tggccggcgc aactatgagc tgaccgggca gggcatcggc gtcgacctca 8100
tcgcggatcc agatcgtctg tccgacccga aggtgggcgc gctggccgct ggctggtact 8160
ggagcgtcaa cggctgcaac gcgctcgccg ataaggacca gttcaccgct atcaccgtgc 8220
agattaacgg ccctgccaaa ctcggccagg atgaccgggt ggcgcgctgg aaactggcta 8280
aatctgtttt attggcttaa ttattcaacc aaacgttgaa taaacaaccg cagctggggt 8340
aagatgaagc cctctactac acgatacggc ggaacttact ttggctgctt attacaatga 8400
gtgggataaa gacacggccc agtggctccg ggaactcatc aaacgcggcc tgatacccga 8460
cggctatgtt gacgacagga gcattgtcga tgtccatcca gatgacctca aagaatttac 8520
ccagtgccac ttcttcgctg gaattgcagg atggcctctc gccctcagaa tggctggatg 8580
gcctgatagc cgacctgtat ggacaggaag ccctccctgc cagcccttca gcaacgccgg 8640
caaggggctc ggggcagacg acccccgaca tctcgctccc gcctttgccc gcctcgtcag 8700
agagtgtcgc cctgcaaggc tttttggcga acaggttagc gcagcggtta agaaagacct 8760
gtgggtcgat gatctacgga ctcgactgga ggcagaaggc tacgcctttg gattttccgt 8820
actgccagct gctggcgtcg gtgccccgca taaaagagag cgaatctact tcggagccgg 8880
gcttctggta taccccgacg acgaacgtca acccacagcc agcgacagca cgcggcctgc 8940
agacactgtt cggtcaagct cgacacctgg cggcgtggcc gacggcagcg gcttcggacc 9000
catctggcgg tggctcagcg agcatcgcgc tccgcaagct atcaggggac aagcgaccgt 9060
cgggggcgag tctgcattct gggctccgcg acttcgtgca actggcggcg tggccgacgc 9120
caacgacgag agactggaaa gatgggtcgg aatgcttcaa cgtcccgacg aactcattgc 9180
tgggacgtgt ggtgtggctg gcggaccagc ctattcgcat aacagcttct gggacagtgc 9240
tgactggctc ggatgccgcg atgggaagct caggccagtt agacccggct cattcccgct 9300
ggctcatggg attcccggac gtgtggtgcg actgcgcgcc tacggaaacg cgatcgtccc 9360
gccgctcgcc gcggagttca tcctctcgtt cgaagaagcc atcgaagacc tcatcggatc 9420
tggacgagct gatttagacg aactcatttg accaacgatt caactattcg ttgactaaac 9480
tacaaagcgt tggctatagt gaaattgttc tcctgacagg tcgtggcgcc gcaccccggt 9540
ttcctccgtt tcccgggatg cggcgcacct tcctatgaca cacaacaggc gagggaatta 9600
ccggaagcaa cgttgcgact cgacacgcag cccactgtgg taagtagttt cctctccgtt 9660
gtgtgtgaat gcgcaggctg cagcgcccag attacatgcc cgtatcccga actggttaag 9720
acatgattct ggaaagacga tggaccacag aacgccatta atggcggcgg gtaaccgcaa 9780
tgaggaagac gctccacggt ctcaaactcg tcatgaaaag gtggaagccc taagccggat 9840
atcagccccg gccaccacaa cgcaacggcg cggtatagca tcaattggta atgcagcgga 9900
ctcataatcc gggagctgaa ggttcgagtc cttctgccgc cgccttctcc accactgcca 9960
tcggcatagc cttgtcgtga agcctctccg ggctcaggtg ggtatagcgc ctcagcatat 10020
tccagtcgcg gtgtcccgac accagcgcga cctcctgaat ctcgtagccc gcttcgaaca 10080
gccggcagat gccctcgtgg cgcaggtcgt gccagcggag gtccaccagc cccgcgcgct 10140
ccaccgcccg gcaccacgca gcgccgatgg acccggtctt gtaagggaag atctcgccgc 10200
gctggcgcac ctgacgtttg atgatgtcga aggacctgcc cagcagcggc acggtctggt 10260
cattgccctt tttcagggtg ggatgcttac ggtcccggat caccacggtg cgcttcgcct 10320
catcgacgtc gctccagcgt atccggcaga cctctgccac ccgcatagct gtgtcaatgg 10380
agaaggcgat cagctcgtcc atcgggaggg tggactgcat gttgtcgagg atctgctcta 10440
tctcgtcatc gctgacccgg cgggcgcgtt cgacagacct accggtcagc ccatagttcc 10500
gcagggcgtg gcggccgcgc ttccactcgt cccagtcagg gcgtacctcc cagaaggtgt 10560
cggcgtggcg cagggccatt gcgatgaaga cgaactcctg gtccatcgtg ctgggcgcca 10620
cgccgcggcc tttggtgtag tcgagcatcc acttcgcggt cagctgagag acgagcactc 10680
cgctcagctt acgacggagg gtgcgcatcg tggcgtggtg ggtgcgctgc agaggcttaa 10740
tcggcaggac ctcatcaatg tagcgctgga tcagtacgcc gacgtctggg tcgttcgcgt 10800
ggaacttacc ttcctcgatc gcgccctcca tttcccggac ccatttctcc gcgaggactt 10860
ttttgctaaa ggtcttcgac agagttttgt gtcctttgcg gcggacctga gccctccatc 10920
cttcgccgtg tttgtagatc gatgccatac cgttcttcct tgtgtgcagt gaccactccg 10980
ggccgtgtgc aatccagtgt gcagcccgaa aattatggat cgaggaagta caggtttttc 11040
aatggtctgg caaacgtcga gcgtgatcga aaatggccgt gtttttgcgt ggtgcacaat 11100
ggaattcaat aagcgaaatc agtatcttaa cggcgaaaaa atcttcgcca ttgcccccat 11160
gatggactgg acggactgtt tctaagtagc tgaaatcgcg tcgatattta ttttcgattt 11220
tccctgtgtg caaattctgt gcagtgcgtt tccgggtgca cccggcgtgg tagctcgtgt 11280
gcagttctca accatcactt gaatgttcac cttcccgtga ggcattatta aactttaaag 11340
acttcaggac attcgattgt ggcaacgacc aaaacgacga agcgtggccc cggcaggcca 11400
ccgaaaaatc cccgggcgaa gaaggcggag accccagctg ccgatggact ggacgacctg 11460
atcggtgccc ccgagcagcc ttcagacgaa gacctgtcgc tggatatggg taccgtctac 11520
ggcggcgtgt cggcgcactg gctgagccac gtcttcggga tggaccgggt gacggtgaag 11580
aagcgcctcg cggagggcaa gtgcaagatc gtcggcaagg gccggaccgg cgcgcccatg 11640
tacctggtcc gcgatgcggc tgcctggctg gttaagccac aggtggacat cacgagctac 11700
attaaatcgt tgcgcccgaa tgacctgccg ccgatcctga acgccgccta ctgggacgcg 11760
atgctgaagc gccagaagtg ggaagagaac gccggcgacc tgtggcgcac gaacgacgtg 11820
atggacgtct tcggcagtct cgcggccacc ctgaagtcga ctatccagct ttggccggag 11880
caggtctccg ggctgacgga taagcagcgg ctggagctgg agcaacggtg cgacggcctg 11940
ctgaacgcta ttcaccacat cctggtggaa tccccgaacg ggcgccgcac cccgagcagc 12000
atggaagagc ctccggagaa ggaggacgac cttgtttaac agccttgagg aaatgattgc 12060
agccgtcgcg cctacagtac actcgcagga gcgtctgacg gtggccgaag cggcagagaa 12120
ataccgcttc atcaacaacc ccggctcgta tgtcgggatg tgggacaatg acttcgcccc 12180
gtacctggtg gagcctatgg aggtgctgac cagcctggac ttcacgggga tggtcttcgc 12240
cggccctgcg cgtaccggta agtcggacat gttcttcaac tggctgacgc atacctcggt 12300
gaccgacccc gcggatatga tgatcgttca tatgacccag acggttgccc gcgactggtc 12360
ccagaaggac ctccggcgcg ccttccggaa cactgatgcg ctgggaagga cggtgatgcc 12420
cgggcgcaac aaccagtcca cgcacgacat ccggtttaag aacgggatgc acctgctggt 12480
gaaatggccg acggtgtccg agctgtcggg taagacggtc aaatacaact ggatcgccga 12540
ctatgaccgc atcgcggatg acatcgaggg ggaaggtaac gccttcggcc tgacccgcgc 12600
gcgtgcaacc acctttaagc gccgcggcat gacggtggct gaatcctccc cgggtcgtga 12660
tgtcaccgat acgaaatggt tgcctccatc cccggactct cacatggcgc caccatgtgg 12720
cggtattctc gacctgtata acagcggaga ccgccggcgc tggtactggc gctgcccgca 12780
atgcaacgac cccttcgaac cggacttcaa gctgctcagc tggccggaca ccgacgaccc 12840
gctggaagcc ggcgagcgcg tggtaatggt ctgccctcac tgcggtggct tcatccatca 12900
cgacgcgaat gacgcggcag ggctccccgg gaagtatgag atgaatatcg gtggccgctg 12960
gctccgggaa ggtgaaatct ggctaccgga tggctctctc ggcggtaacc cgcggcgtgc 13020
ggagatcgcc tcgttctggc tgaaaggtcc tgcagcggca ttcgcggact ggaagaagct 13080
ggtggtcgac tacaaaatgg cgatggacgc ctatgagcgc agtggtgacg aaggtccgct 13140
gcgggtaacg gtcaacaccg gtcagggcct gccctactca ccgaagatcc tgtctgcagg 13200
ccgcaacccg gaagacgtga aagcgctggc gcgtgatatt ggtgaccgcg tggtcccacg 13260
cggcgtgcgg ttcctcgtag cgacggtcga cgtgcaggct ggcgcccgct ccagcttcgt 13320
cgtgcaggtc cacggcttca gccgctccgg gaatatcgtc gtcattgacc gcttcagcat 13380
caagaaatcc gaacgcctgg acgaagacgg tgaacgccac cgcctgcggc cggacgcctt 13440
tctggaggac tgggacaccc tcattcatca ggttctcctg cgctcgtacc cactcggtga 13500
cgacagcggc cgtcggatgt cgatcaaggc cgtcgcctgt gactccggcg gtaaagaggg 13560
cgtgacgtcg aacgcctata acttctggcg ccgcctgcgg gactccgacg gcgaagagtt 13620
cccggccaac ctgcatcggc gtttccatct ggtcaaaggc tcatcacaga agacggaccc 13680
gcgcgttcgc ctgtcgtacc cggattccga acgtaaggac cgccatgctg gcgcgcgcgg 13740
ggaaatcccg gtgctgatgc tcaatggcga cctcctgaag gactacgtgg acacgctgct 13800
cggcggcaag caggacgacg gtactattgt tggcgggcgg atcgtcttcc ccagctggct 13860
tccggactgg ttctacagcg aggtgtgcgc agagaccaaa actgagaagg gctggcagaa 13920
cctggcgaaa ctccgcaacg aaggtctgga cttgctctgc tacgcgattg ccgtggcagt 13980
gtatcgcccg attttctggg agcgcatcga ctgggataac ccggagggct gggcggaaga 14040
ctgggacgac aacgacctgg tattcaacga aggcggcaaa accattgatg aggaccagga 14100
agaagatgat accgaactcg aagatttggg acgtctgctg gcgtagtgtt caactttcca 14160
ttggaaattc aactggacct ggaatacact tggcgaaaca cccgaccgga atctcattat 14220
gcctgatttg aatgttttgc tggctgaagc tcgcgctgcc tatcatcagc tgatgatcgg 14280
gcaaaacatc gtcagcctcc gtgacagcaa cggcgagcag atccagtaca ataacgcaag 14340
cgcttcccgg cttgctgcgt acatcgccca gctggagatt cagctgggca tcgccacgac 14400
tactggcccg atgcgtacct ggatggggcc atgacgaaaa tcgtatttac ggatgaccta 14460
atcggcgacc cgctggaagc cgtacagaac accggcaaag agctggcgat gttcggcaac 14520
ccctcgtatg acgccgccag ccagttttcg gaagagctgg cgctgtggtc tacgcctatc 14580
cagtccgcgg accaggaaat cttgccggag atgggggtca tcacgcctcg cgtgcgtgac 14640
gtgacccgca atgactcgct gatgcgcggc gccctgcaga cgcagaagga cagcatcgtc 14700
ggcgagcgct tcctgctgaa ctccacccca aatacccaga tcctcggtct cgatgaagtg 14760
tgggcggaag agttccagga agaggtcgaa gcgaaattca ccctctacgc tgaaagtctg 14820
atgaactacc cggacgccca gcggaaaaac accctcactg aaatggttcg cctcgcggtc 14880
ggcatctacg gccagaccgg tgaagtcatt tcgtccgtcg agtggcttcg cgactccggg 14940
cgcccctaca gcaccgcgct gcagttgatc gagaacgagc ggctgtctaa cccgaacaat 15000
gggatggaca ctcgtctgct gcgcggtggt gtacaacgga acagcttcgg cgccccgatc 15060
ggctactaca tccgtgacgc gttcccgacg gactatctcg acttcgaaaa tgtgaactcc 15120
tggacgtatg tgcccgccac gaagccgtgg ggccgcatcc agatgattca catcgttgac 15180
cagtggcgcc ctgaccagac ccgtggcatc tccaacatcg tggccgcgct caaagagctg 15240
cgcatgacga agaagtatcg cgacatcgtt ctgcagtcag cggccctgaa tgcgacctac 15300
gcggccagca tcgaatccga tctgccgact gacgtggtga tggcgcaggc gggaggcgga 15360
gacccggcgg cactgtcgaa gttcgcgaag agctacctga gtgagatcgc ccggtacacc 15420
aagaattccc gcaacctcgt gctcaacggt gtgaagatcc cgcatttcta tcccggcacg 15480
aagatgaacc tgcagaacgc agcgacaccg ggtggcctcg gcaccacgtt cgaagcgtcg 15540
atgctccgct acattgccgc gtctctgggc ctgagctacg agcagttctc gaaagattac 15600
acgaaggcca actactccaa cctgcgcgcg gcgctggcgg agaccaacaa gcgtatgcgc 15660
gttgagaagc gtcgtgtggc tgaccggttc gccagcctgt tcttccgcct gtggctggaa 15720
gaggcgctga ataagaacga aatcacctcg ctgccccgca atgcccctaa ctggtacgag 15780
gggcagaatg ccgacgcgta cagcgagtgc tcgtggatcg gtgccaacat gggccagatt 15840
gacggcctca aagagaccca ggctgccgtg ctccgtctga acaacggcct gggtaccgct 15900
gaggatgagc tggcggcgct cgggaaggac tggcgtcagg tttacaagca gctggcgcgc 15960
gagcagaaat tccgtgagaa gatcggcctc gtgctgggct ccgagaagac aaacaccaac 16020
atgatgaacg cggcgagcgg caccccttct gacgaaggcg cgaagccccg cagcgagacc 16080
agtgaggaca ataccgatga gtaacatctg ggctacccgc gtagccaatc agccggttat 16140
ggtcggtatc gccggcgcag actggctgca gcagcatctg aacggcgcgg caatggcgtc 16200
agcgcagctc gatacccgcc tgtccgcgga caccccggtg atgcaggacg acttctggcc 16260
gtcgaaagac agctggctgt cctacttccg cccgtacaac gtctcgcagg gcacgctgta 16320
cgtcccgatc aaggggatgc tggtccacga ttacgggtat gctctcggcg actggctgac 16380
gggctacacc tacatcgcca aagcctttga gcgcggtatg gaagacccgg aagtcgagcg 16440
gatcgcgatg gtcatctctt ccggtggtgg cgaagtggcc gggaactttg acctcgtgga 16500
taagattttc tcgatgcgcg gtccgaagcc tatccaggca ttcgtgaatg aggcggcgta 16560
ctccgcggca tactcgctgg cgtctgctgc ggataagata tcgatgaccc gcacggccgg 16620
cgtaggcagc atcggcgtgg taacggcgca cgtggactac agtgaactgt acaaagacgc 16680
cggcatcaaa gtgacgttca ttcatgctgg cgaccacaaa gtcgacggca acccttacga 16740
gcctctgccg gaagaagtga aaaagcggat gcaggcgcgt atcgatagca tgtatgatat 16800
cttcgtttca actgtagcgc gaaatcgtgg ggtggacgag aaggccatcc gggataccga 16860
ggcactgacg tactcggctt ccgacgcaat ttctgtcggt ctcgccgatg aagtgctacc 16920
ttttgaagaa gctgtggccg ccttctcggg cgcgctaacc gatgatccgg aagtagaccc 16980
ggacgaaaac tctggagatg aaaatatgtc ttttacccag gaagatctgg ataacgcccg 17040
agcagatggt gtgacgcagg gcaaagctga aggcgcaacc gccgagcgtg cccgtattca 17100
aggcatcctg actgcggaag cggcgaccaa tcgtcgtgag gtagctttcc acctcgcgtt 17160
gaatactaac caatctgtgg aagaagcgac tgcgctgctg gcgatcacgc ctgagcaagc 17220
tgcggcccct gctaccacca cccctgccgc caatgctttc gagcaggcga tggcccacgg 17280
caacccgaat atccaaccgg gtggtgataa cgccgaagcc gcagagcagg acgaatccgc 17340
gaaaactctc gctgagttcc gcgctgtcaa cggcctcaat aagaaggact aaccatcatg 17400
gcgattaccc cgactcaacc aaccccgggt ctggctcagt atgagtcgga taccgtcggc 17460
ggcctggtcg aactgtgggc cggtgacacc ccggctccgg tgaccatctc cggcaaatac 17520
tcggcgactc tggaagccgc cggcatcccg gctaacaccc cggtgagcct ggactatgaa 17580
accggcgaca ttgcgctggt ggacggcacc accgtgacca aagccaacgc aatcaccgtc 17640
ggcgctctgc tgccgcgcgc tggtggcacc ggcgggtcga tggcggtgta caaggcaggc 17700
tgcgtcaata tcaaggcgct gaactggccg gcgtcgttcg ataccgatgc gaaaaaactg 17760
gcggcgttcg acctggctga atgccagatc tacgtcaaag tcccgtacta ctcttaaggg 17820
ccactgaatc atgacgattg aaatccgtcc gcaggacacc agtacccttc tgggtatgta 17880
ccgtgacgtg gaagccccgg tgaactactt ccgtagtctg ctggtatctt ccgtgtacac 17940
ctccactgat gagtggatcg acttcaccaa gatcacgaag agccgtaagc tggcgccgct 18000
ggttatccca actgcgcaag gccgcccgat cttcagcgaa gcgtccaacg cggctcgctt 18060
taagccggcc tacgttaagc cgaaggaccc gatcagcccg tctcgtgtgc tgaagaaacg 18120
cccgacggag aacatcttca ctccgtcgac gctgaccccg tatcagcgct atctgcagct 18180
gctgggggat atcatcaccg agcatcgcgg atccatcgag aaccgtctcg aatggctggc 18240
gtctcaggct gcgctgtacg gcaaagttac gctggaaggt ccggactacc cgaccaccat 18300
cgtggacttt gagcgtgacc cgtcacacac catcacactg gcgggcactg acctgtggag 18360
caacccggac gccccgatcg ttgaccagct caacgcctgg gtcgaaaaag tccgtcgcgc 18420
ctcattcggt ggcccggtca accgtgtaac catcggcaag aacgtcgtcg gtccgctgat 18480
gaagaacaag cagatcctgg ctgaacgtga cctgatggtc cgtgacaccg gggtgagccg 18540
tacccgtgtt atccgtaacg gggactacag cgagctggtg atgaccatcg gcaacctgga 18600
aatctggacc accagcgact ggtacgaaaa acctgatggc accatcggcg agtacatgga 18660
cccgaacggc gtgctgctga ctggcccgaa cgtgaacatg gtggaatgct acggcgccat 18720
cctggacatc gacgcccagc tgcaggccct gccggtcttc atgaagcagt ggaagaacga 18780
agacccgagc gtggtgtatg tcatggctca gtctgcgccg ctggaagtgc cggtgaaccc 18840
gaacaacacc ctgttcgcaa ctgttctgta agagcggctg gtattggcgg tctccgggcc 18900
gccctttttc cagaagccga ttgaggaatg agagatgcca aaagtaaaag cagtccacca 18960
gctggttatt gacgggcagg tcattgcccc cggtaagact gtcaacgtcg ccaaagagca 19020
ccttgaccgc cttgttactc tgggcgccgt gaccctggct accggtgaag cggcggaaga 19080
cgctgtagtc accgaagcgg ccaaagagca ggttgcccag gtgaccgaag gctccgacgc 19140
cccggcggaa gaaaagtccg ctaaaggcgg caagtctgcc aaaaagtcta acgacgatct 19200
ggtgtaagcc atgacgttcc gtgaccagaa acgcaaagcc cgtcggcagc tgcaccagcg 19260
gctggcggag ccggttctgt acctcacgga cccggatgcg acgcccgtgg atatcacggt 19320
gcgtctgcat ctccgttttg atgcgctggg tgagcttctt accgtgtccg caggtttcgc 19380
ggaccgtcag gagctgaccc cgcgtattat ttttatgaac gatcagatta gccctaagcg 19440
caacgccatc gtggtgacca aagatatggg cgccttcaac atcgagacgg acgttgcccc 19500
ggacgatatc acgaccaccg caatggtcac cccggtcagc aagtctatgg ttcagtcgtg 19560
gggatgggac ccggacgcgc tgtggctggg cctgacgccg ccagcgattg tggggtgacc 19620
tatggcctac gtcttcgcgg ttgaagggct ttcctcactg gaaaacatcg ataaccttcc 19680
cgaagaaatc ctcctgaaag cccggcaggc gattaacgcc gctgccgatc gcgcgcgcac 19740
gcaggctgcg aaagacatcc gcagcgaact gaacttcccc gcgcgttatc ttactgacag 19800
gctaaccgtg cgcgaacggg cccgcgggac gaacctgcag gccgtcatct ccgggcgcga 19860
ccgcccgacg tcactggccc ggttcgccac cagcaccaac atccaggcgt cccggaagaa 19920
gggatttgtg caggtcaaag taggcaaatc cacgaaacgc atctccggag gattcctgat 19980
taagttgagg aatgataata tcggtctggc gatgcgcctg aagcctggcg aaacggtcaa 20040
agggaagcgc gcggcagcga aacgcttctc cagtaaagac gcggacctgg tgctgctgta 20100
cggccccagc attgatcagg cgtttcagac agaggtcgac aagactaaac ttactgacga 20160
cacggcgcga tttcttgaaa acgaatttat tcgactgatg gggatttgat gatggctgac 20220
ccgcttcgcc tccgtatcct gaaggcgctc actgcagaat tcgagcagat gacagacgca 20280
aacggcgaga gcatggccgg aaaggttttc cgtggtcgtg accactttgg taatgatgac 20340
ccgctgccga tgatctctat ccttgaaggc gtggatgaga aggccatcgc tggcaccagt 20400
gcggagatgc cgcgcggccg ctctgtccag cagtcacagt gggagctgct ggtgcagggt 20460
tttgtggaag acgaccgcta taacccgaca gatcccggct accgtctgct ggcaatcgtg 20520
aagcagaagc tggcggagat ccggaatgtg aaagataata ttctcggctt tggtccgaag 20580
gtcaccgacc tgacgttcag cgccggagtg gttcggccgg cagacgaagt atcggataaa 20640
acctacttct ggctgaaggt ccgaatgaac gtcgcggaag atcacagcga cccttacgct 20700
tgacgtaaga ttcaactatc tgtagccatt tcaacgatga ggtgaaagta tggcaaagca 20760
aaataactac acgctgggtc gcgggaagct gtactttgcg cgatttaagc cgggcactac 20820
cacgcctggt ggcgaacgtt atctgggtaa ctccccggaa gtgagcttca gctctgacag 20880
ccagcggcta gaccactaca acagcgactc cggtgtgcgt aacaaagacg cctccgtgct 20940
gctgcagatg gactatgctg gtggtttctc tctggatgat atccagttcg aaaacctggc 21000
tatgctgttc ctgggtaaca gcggcgtcga aactgtagcg gccaaaaccg cgcagactga 21060
gacgttcacc aacgtaatgc cgaagctgac ctatcagctg ggtactactg cctccacgcc 21120
aaccggtacg cgcaacgtta ctgtcgccag cgtgaaggat tcgaccacca cctctaccac 21180
ctacgcggcg ggtaccgact acgttgtgga tgaagcgacc ggtcgtatca ccatcctgga 21240
agggaccacc attccggcgg atggtggcat cacggtagag tgggcgagcg aagcgtacac 21300
tcaggaattc gcggtttccg acgcagacac catcgaaggt cagctgcgct acgtcgccga 21360
taacccgatg ggcgagaaca tcgactacct cctgccgtgg gtgcagatca ccccggatgg 21420
cgattacgcg ctgaagggcg atgactggca ggtgatgaac ttcaccctgg ctatcctgaa 21480
gaaaggcgac ctcaaagcgg tatacgctaa cggccgtcct tacgtatcat aaggaaacac 21540
gactatggct ttgaaggaca ttcagatccc gaaagccgat gtctcagttg gcgcgggcgg 21600
ctcttttgcc gtccgcggcc tttccactgc cgacatcgag tattgcgttc gaacctacgg 21660
ccctgagctg cgtaagctgt gggacgattt tgttaacggc aaacgaaagc ccgaagaagc 21720
gctgacggaa gccggtttta ccagcatctt ttcacaaatt gtacgtgaag ccccggcact 21780
cgtgcagggc atcatcggtc tggcggccga cgcggatgaa gcggatatgg ccgtactggt 21840
caagctaccg atcaccgtcc agatcgacgc gattaccaaa gtcgcgatgc agaccctctc 21900
ggttgaaggt gagccgggaa aagcgatcga aaccgtgctg gccgcgctcg gcagcctaaa 21960
cgcgttcatg ggaagcgcca acgcggagct ggcgaagagc taacgctcga cgcctgggtg 22020
tggggattac gccggcaggt cagcctgctg atggctgccg gccatcccga cgccgcgttt 22080
tatcccgtgc accgggtgtg ggaggaagcc cggttggtcg tccaacggga gaacggccga 22140
gaagtcaccc acgccctgct aattcagctc gcggtttcgt cggcgatgac tgggaaaaag 22200
agcgcccaga cagccttcaa agacattatc gaggaactaa cagatggcga agggtgaagt 22260
cgacctcatt atcaaggcga agaacgaagc gtcgaaatcc ctggacgcca tcacggcttc 22320
gctgaaaaac cttaccgacc agcagatcat cgccggcgac agcgccgaca aagccgacgg 22380
taagctggcc tccctttctc tggagctgac gaagctccgc accaacgcac agaacctgca 22440
gcagctggcg aacatcggcg cggtcatcga taaagcgacg gccgcgctgg agcgccagaa 22500
ggaaaccctg cagcaggcga acagcgagca gcagaaactg gcttcccagt cggagacgat 22560
gaagtcccgg cagcaggagc tttctgcctc cctgaagctg gctaccgccg accttgagaa 22620
gcagaaggca gcggtcacgt cagcgcgcag ttccctgtcg gagctgaaca aagaggcaac 22680
gacactcacc aatggtcagc gcaacgccca gcggtctctc gatgccctga cgaagctgat 22740
cgcgacgcag gaggccgctc tggagaaagc ggccgccaaa cacgctcagc tcgccgctgc 22800
agtcgacgca gctgagaagc cgaccaaacg ccttacgacg tcgctggagg ccgctgagcg 22860
cgcgctggcg aagcgtcagg ccgctctcga cgcatcacgt cagaaggaag ccgggctgcg 22920
cgataccctg acgcagaacg ccacggcgca ggagaagaac gcagccgcga ttgccgaggc 22980
caccagcaag ctgcagagcg agcagaaagc cgctgacgca gcgaaggcag cggtcagcgc 23040
cctgaacacc gagtcctcca gcctctcgaa aagccagcag tcactgtccc gtgacatgga 23100
gaaatccgcg gccacgacag ccgagctgca gaaaggcctg gacgcctcgc aggcggagtt 23160
cagccagatt caggcagtcg ccgacaaggc ccgtgcgaag gtaggccagg cttccgcctc 23220
gatgaccgac gtcggccaga gcgctgtgca ggccgcggcc cagctggcga cttttgccgc 23280
gcgcatgaag gtgctgcagg caggcagcgg cacgtcatcc ctgaagacaa cgctgtttga 23340
cccggcggca gtgactgacg cgctgtcggc gttgagcaaa gcacaggccg tcgttcaggc 23400
taccgagcgt gactactccc gcgcggccgt gtctgccgac gacctgaaga acgcgacgat 23460
cgccgccggt aaggccggcc aaacgctcag cacggtcacc accgccgtca cgcagcagaa 23520
agccgctgtc gacggtgcag aggcgtcgtg gaaagccgca gaggcggaag tcaagcggct 23580
cgccatcgcc atgcgagaag ccggtcagcc gtcggaacag ctggcagctg ccctcggtca 23640
ggcgcagggc caggcgaagc tcgcgaaaaa cgaattcctg aatcagaaaa acgtcggcga 23700
ccagctggca aaagcgctgc agcaggctgg cgtaggggcg ggcacgctgt cgtccgcaga 23760
ggcgtcgttg gccggatcta cccgcgcagc cacctccacg atgaaccagg ccacgcaggc 23820
cagcaatgcc ctcgccagcg cgcagaacaa cgcccagcag tcggggtccc gtctgcagag 23880
cttcttcgcc agcctggtat ccggtggcaa ccgcgttgcg acagcagcag gtcaggcagc 23940
gggtggcctc gccaagatcc gctctggcgc cgtttcggcg tctggcccgg taggcagtct 24000
gaccggggaa ctccgtgggc tggtggccca ggtggccggc ctctacgcga tcaaggaagg 24060
cattaccggc atcatccaga cgtccaacca gttcgacgca ctgagcgcga agctgggggt 24120
ggcgttcgcc ggcgacgtga cgaaggctaa ccaggcgctg gattactcac tggccgttgc 24180
ccggaacctg aaactgccgc tgctggagac ggcgaacagc tactctcagc tggcatccgc 24240
cgcgcgcggc acctcgctgg aaggcgacgg ggtcaacaag atcttcaccg ccttcgcgca 24300
ggcagcgcgt gtcacccgga cgtccaccgc cgaccttgac ggtatcttcc gcgcgctgac 24360
gcagtccatc tcgaaaggca aggtgcaggc ggaagagctg cgcggccagc tcggtgaccg 24420
tttgccgggt gccatccagc tgatggcttc tgctctgggc gtaggtacca aagacctgga 24480
gaagatgctg gagaaagggc agctgaccac cgacacgctg gtgcgcatgg ctgccgaagt 24540
atccagccgt gtggcgccgg agctggagaa agcccttaat agcccgcagg ccaaactgca 24600
ggcattccag aactcgtgga ccgagctgca gctaaaactg gcacagtccg gtttcctgga 24660
tgcgatcgcc aacgctgccg agcggttcgg cgacgcgctg tcccgtcctg acgttattca 24720
gtccgtgacc gaactaggcc agggtctggc gaacctcgtc aactatttcg cccagctgga 24780
agacccggtc ggcaaggtca ccaccctgtt tgaggtgctg gtcggcctgc agctggcgtc 24840
ttggatcggc ggcatcatta ccggcctcgt gtcgatggtc tctgggctgt acgcgctggc 24900
gacggcagcg gccgctgcgg atatcgcgct agcgccgatc ctcatcactg tgggcgcgct 24960
ggcggcgttg ttcgcgctgc cgtggctcgc gacctgggca tacgacaact tcccggtctt 25020
cgcggagctg gtgctcaagt cgaagggcgc ggccctgcag gcgtggtccg gtatcgttga 25080
gggctggaac gtcgccggcg cgctgctggt gaactcgttc gaacaggtca tcaacaacat 25140
catggcgatg tggcgcagca tgatgagctg gattgcgacc acctccagtg atctgctgag 25200
caaagtcggc ctcggtgggc tggtggaagg atgggcggcc gaagcacaga aagcctcgga 25260
agaagcaggt aagaaagccg cggactccca gaaggcccat gagcaggaaa ttaccagcat 25320
ccacgccaaa gcagcgaagg accgcgcgga tatcgatgcg gatatcgccc ggcaggtgca 25380
ggacaaactg acggagatta gccgccgcgg ggagaaggac cgggcgaagg gcgccgttgt 25440
tcctacagtg cccggtgtca acgctggcgc cggcctcggc acggtaacgc cgccgtccgg 25500
cacctttaaa ccagatacct ctgatgcgga tgccaaagct gcagagcgcg cggcgaagaa 25560
gcgtgcacag ctggagcaga gcgtcgctga ccagatcagc tctatccggg cgcgtctgga 25620
ccagaaccgt gcgaacgacc tggacaccca gctgaagggc gtcgaagaaa agtacaaggg 25680
cctttatgac gatctgcgga aactcggtct cagcgagacc agtgagcagt ggaaacaggt 25740
cgacgcgctg aaggctcagg agatgcagct cgtccgtaat aaagcggcga aggcagaaca 25800
gcaggcccaa gataagaaaa ctcgtgaaga catgcagaac atcaatgacc tgatgtctct 25860
gcgtcgagag ctgctggaac agattaaata cgcggaggac cacggggacc ctcaaacagc 25920
taacaagttg aaggagcagt tcaataacgt caacggcctg atctccgcag ccgcggataa 25980
catgattaag ttctgggagg ccgcaggagg tccgaaagct gatcttgcta ttgctaagct 26040
caaggctctt aaagacgggc ttaaaaatat tgatgatggc gctattctca cagctgacaa 26100
tattaacaag acgttgcttt cgactgcgac cagtgctggc gatagtttta ttgataaaat 26160
cgccgaaact ggggacgtct ttgggtccct gaaagaatcg tttcttgact tcgtaagctc 26220
cttcttgacg ggcatcgcga agatgatcat gcagcaaatc atcttcaatg ccctgtcatc 26280
tgccggttca gctggcggcg gcgggggcct cggagggatt attatgagcg gtatatcagc 26340
gatgaccggc tcggctcaca ccgggggtat tgccggatcg ccgacactga acaagcgctc 26400
cgtgaacccg ggcgtcttcg ccaacgctgt ccggtatcac acaggcggcg ttgtcggcct 26460
gcagccgtgg gaagtgccga ttatcgcgaa gaagaacgaa gaggtgctga cggaggatga 26520
cccgcggcac attaacaacg tcggcagttc aacagaaagt ggaaacggca actccggtat 26580
gtcaaacttg caaatcatca atgccatcga ttccgagtcg gtggtgcaag cggggctttc 26640
gtcgccggcc ggagttaaga cagtcatcaa cctggtcaaa gcgaacaagc agacgtttaa 26700
atcgatactg gcttaacggc ggaccggaat ggctgacaat gaaatcttga tgaaccccga 26760
agggctggtg gtcaacgctt accgcgatgc ccccggccgc ggggattact ttaacgggtc 26820
ttccggtacc tcggaaggcc agttcctttt cattatcggg atgctggatg cttacgtcgc 26880
cacgggcgat gagcgggcac tggcaatggc tgagagggcg ctgaacgcca cgctttacac 26940
tctctaccgc aactcgccta tcccggcgca ggtcaccgag cagaagatct tcgcgcctca 27000
ctggctgttc gcggtcaagt accctttcaa atcgagcctg atcaactacg acctggtggt 27060
gaacttcacc aacggcgtcg gggtaatccc gaacaacgac gtccgctacg tctggtatgc 27120
gcggtctctc gactccacgc tgctgtggac caacccgtat tccccgctga cctccggcac 27180
gcgctacgag gttgcgagct atacgcctgt ggctggcgga atgcaggtca ccctgcagac 27240
ggcgtacaac ggccagctcc gcgtggtcca ctctgaacag aacggcccgg tcatcgaggt 27300
caatgagccc tacgaggcat ggccggactg gcgtaagctg gactccactg agatcgaggc 27360
agcgtgcgac gtcttcatct gggcgtaccg cgccttccag aaaggctacg aggtcaccgg 27420
caaccagacg tgggctgacg cagcacgcgc cacccgcgag caggctgcta tcgctatcga 27480
cctgaacgac ggccgggact ggctgaaacc gacgtggacg gatagcccgt tcgccgacgg 27540
caagtgcttc agctatgtcg accggtcacc gcctccgggc tttggcgtcg atagttatgg 27600
ccgggtgcag atcgacatcc ctcagtatct gtctggctcg ggcgaggtgc agtatggccg 27660
cgcctcgatc ggcgatacct atgccgacgg cgacacgacc accatcacgc tggggtcgaa 27720
caagcctgtc acggtgacga tctacatcga ccagtaccag gcttacgcgg acgcgaatcg 27780
ctattccgcg caggtcgcgc tggcgggtac cggcgaccag acggtgaccc tgaaccgtgc 27840
gagctttaag aacaacgtcg gggctacgct gccggcggac tcccccgttt acacggttgg 27900
cgtttcatcc aacaaccatg acccgcacac tctgtggatc acgcgcatcc gccagagtcc 27960
gccgcgcgac attgcctatt accccggggc tatcccgttc acggctaact ttgccggcaa 28020
cccgccgatg ctcatcgact ggcgcggccc gatttacgcg ggctaccagg cgccgcagat 28080
gtggaccatc gtcggcaacc cgggcgccgc gctgacgtgc gtctacctgc tgacggatgc 28140
ccagaacgcg tgggtggcgc agactggtaa aatgcgcggc ccgttcgccc cggtttacta 28200
cttcgaccgc gatgatgcca tccagtacgg cacgccaggc acctttggct ggaatggccc 28260
ggatcccaac acgaagtggg gcgggtacca gtaccgcccg ctggcggagg tagccgagtc 28320
cttctacggc gcgacgctgg ggacaacgta ttccaacgcc tgcctgaacc tggttaccga 28380
cttcctgcag tatttgagcg cagataagaa ctggataccg tattccccgc caatgatggc 28440
cgggttggcc tcgaccgtcc gcaaatccgc gctgctgatg tacgacactg atgagcaagc 28500
ggctgctgat atcgacgcgc tgccgtatcg ccaggacggg ccgccgacgg actacccaca 28560
gaccgggtca gaggtcaatt acaacgagcc gcatatggtg gcgttgatcc tgcgcgcctt 28620
catcttccgg gataccaaac tgcggccgac aggcggcagc tgggactcct gggagcacga 28680
cctgtttacg aagtgctacg gcctgctgaa gaccatgtac gtcgagacgg gcgtgatggc 28740
cggcacgttc tccaacgacc cggataacca cgaatggtat ggcttctggc acggcgagat 28800
cctgtcaacc ctgacgcagc tgctgacctg gtcccagaag acggggactc agtacgcgaa 28860
tgtcgaagcg gatgcgcgca agtggctaaa ggggatgacg gtctgggcgg aggctaactc 28920
cccgaccggt gactccccgt ggggcgctgc catgtggccg ttcagccctg actgggcgaa 28980
tggggtcaac gaggctttcg agttctcgac caatatcatc acctcgtttg acggcagcga 29040
gcagcgtatc gcccgccggc ccaagcaccg ccgaagcctg accttgcgtc ataccctgac 29100
gacgggcgac cagtcggcgt tctatggcgc tatcctgcgc gcccggcaga accgtccgat 29160
gctggtgccc cagtggcaca tggctagaaa gctggcagct gccgcgtcca tcggccagga 29220
gtatctcgac ctgagcagcg cgccgccgga cgactgggaa tccggtaccg ccctcgtgct 29280
ggcgcagggg ccgacgactc gcgagatcaa ctacgttact acggtggaag gcaaccgggt 29340
aaacctgcgc cagccgctgt cgatcaatct cagcacccag gctctggcga tggccgcgta 29400
tatgggcctc ctgaacaaag aactgtcgtc atcgaagccg acgacggcgt atctggtggc 29460
ggagaccaac ttcctcatgc tgccacagga agacggccgg aaggtcccgg cccgcggtta 29520
ccccgggatc ttcgaatacg gcatcgccat gaacacgctg gcagcgctgt acgttcgccg 29580
cgctgcggcg ctcgatgtcc gtatgccgct ggagtggccg gagcgtaacg tcttctcgac 29640
gccggtgcct gagtttacga ctgacggcga tacccgtgag gtggtgaccc ggaagccgaa 29700
ctggatcagc gacgtctcag tggtcgactc ctgggtctat gaggtggtgg actatttcaa 29760
cggtccggtg actccagctg tgggcgagaa cattggccgg cgcacaatgc aggcacgctg 29820
gacattgatg aatgacgtcg actgcatcga cttcctgacg atgctggggc gtctgaaggg 29880
cacccggaaa gcctgctggt tgccgtcctg gagccgtgac ttcgagctga cccgggaccc 29940
ggtggtcgct agtcagctgt acgtccggag caacggcatt atcagcgagg gtattctgaa 30000
tgacgccgcg atcggcatct gcgtcatcac gaagggcggc ggcttcctgt gcgcccgggt 30060
gaacagcttt accaccggca ctactgagtc cgtgctgacg ctcgatcgca acctcgactt 30120
cctgcctaag cgcagcgagg tcgcccgcgt atgcctgctc taccgcgtgc gccaggcgtc 30180
cgacaaatcc gacatcacct ggctcgcccc cgataaggct gaggtgcagg tgtcgtttat 30240
tacggttcag gagtaattat ggcctacgat gatatcgagg acagcgtaga taacggcgaa 30300
ccgctgttct tctacgagtt tatctacgac gtggcgcctg gcgccgcgta tcgctacgtg 30360
gcggacaccc agcgacgggt gatgagcggc aaggtctggc aacccttcgc catcaagcac 30420
gatgagatca cggtatccgg gtccctcgat aagcagacgc tgacagttac cgcgcgcaac 30480
gacatcgcca tcaccgcgct gtacatcgcc ggctccccca gccgcgaggt gcaggtcaat 30540
atctggcgcg gtcatgcgga caccactgac atcgtcatgg agtggaccgg gcgcctgctg 30600
aactgcgcct ggaaaggtcc ggacatcgag atgtcgtgcg agtcgctaag tacggcgctg 30660
acggcgatcg ggctgcgcag gaaataccag cgcggttgcc cgcataccct ctacggcaaa 30720
gcctgcaggg cctcacggct ggcgcataca gagaacggca cggtcaccac ggtcaacaac 30780
aaactggacg tcaacgtcac gctctccgga gcggagacag gattcaccgc cagcaatctc 30840
attggcggcg ttttccgggc gactgtcgac agcggcatta ccgagatccg ggctatcaca 30900
ggcgccacac tgatcggtgg caggcagtgg cgtctctcgc tgatgtcgca aatcccggag 30960
gtcagaaccg ggctggcggt ctccgtctct aaagggtgcc cgcatacctt cgatgcgtgc 31020
cgggatactt tccagaacgc agctaactat ggcggatgtg ctaatatccc cgagaagaac 31080
ccgttcacca ataatcagtt ctaaagtatt gaggtgcttt tatgcccgcc attattgtcc 31140
agatcattgt tgctgtcgtt ttgtcacttg cgtcttacat gctgtcgcgc aagaagcagc 31200
agtcaaacaa catcaaggcg caggacttaa ctacgcccac tgtcgacgcg ggtcgctcga 31260
tccccgtggt ctttggccgg gtgcgcgtga agtcccccaa cttgctctgg atgggcggca 31320
accgctctaa ggcaatcaaa aaatgacgga tatccttgtt cttccctgtg acctggcccc 31380
agtgggcctg tgtctggccg gggcccgtcg gtggtgctct gccaataacg tggacttcaa 31440
acagttcatt gacgaaggca ttcctgtaac ggtgctccgc gccaccgggt gccctctggc 31500
tgagcgcgca tgtcaggccg cagaagagcg agtgcgccag gaggtagata gtgggcagca 31560
gtaagaaaaa atcgacagtc ggttacaagt attacacgac actgcatttc gcgatctgcc 31620
acggcccggt gaactcgatt cggtcgattt ggtggtctga taaggtcgcc tggcaggact 31680
catgggtaca gggccctggc gaccccgtga tgtggaattt caaaaatgaa agtatgttcg 31740
gcggagatga ctccgagggc ggtgcatccg gtagggtgga atttggcttt ggtactgcgg 31800
accagacgat gcacggcgta ctgccgaacg gtacctatga cccggcgcag atgactaagg 31860
ccgcactggg ggtcgacagc ccggcgtttc catcaatggc gatcaactac cgtggcctct 31920
gcgtgctgtt tatgcacgac aactatattg gcaacaacgc ctacctgaaa gacctgtctg 31980
tcgaggtgga gcgctactgg accggctggc aacctggtct ggcgcgcatc ggcgacaaca 32040
tgaacccggc gcacattatt tatgaatgcc tgaccaacga agaatggggt ctcggatacg 32100
actccagcgt tattgatgat gaggccttca cggcctctgc gcagaccctc tacaacgagg 32160
gtttcggcct ttccttcgtc tgggacagcg accaggacat ctacgacttc gtggaccagg 32220
tgcgctcctg catcgaggcg gcgttctacc tgaaccggcg caccggcaaa tacaccctga 32280
agctcatccg cgctggcgct acgccgaagc tgacggtcag cccgtccaac gctacgctgg 32340
agtccttcag ccgtaaggca atgggtgaaa cgtccaacga aatttccgtc acctggcgca 32400
acccgaacaa cgaggaagac gagaccgtca ctgttcagga cgtagcgaac attgaggcgc 32460
agggccgcgt tatccagacc gcgaaggaat atatcggcgt ccgttccgcg gcgctggcga 32520
caacgctggc acagcgagac ctgcagacga tctccgccca gctgtctgct gccgaagtag 32580
tggtgaaccg gcaggcgtgg gatctgatgc ccggagacgt cgtgacacta aactggcctc 32640
cgctgggtat ctcggacctg cagatgcgcg tcactgaagc ggcgcagagc gaaccgggct 32700
ctgactccat ccggttgcag ctcggcgagg atatcttcgg ccgtgccagc ggctcgttct 32760
ccggcgtgca ggaccccggc tgggtcgacc cggcttcacc gccgacgctc ttcccgttca 32820
cgctgccgtg ggagtaccct tatccctacg tcgtcaatta tatggagctg gacccgtcca 32880
cgctaccgga agacacggcc tacggtaccg acctggcagc tggtggcgcc tcgtcctccc 32940
gccgcttgcg gctgtacggg cgggtgacca ccgagaatgg cccggcatgg gaagttctcg 33000
acactggtgc tgtcaccacc gtcagcaagc tggcctctgc gctgacccgt gagcttacgt 33060
ctacggccgc cctcgacggc acgcaatcct tcgacctggc tgcagtggat accgacagct 33120
tcgtggtgct gagcgacggc actcatcagg agatcgcgca ggtgtccggc gacccggctt 33180
ccgggactat cacactaacc cgtggcctga tggataccca cccgcggcaa tggccggcgg 33240
ggaccatgtt gtggttcgtc gggactaccg gtttcgttag cgatgtcact cagtggtcac 33300
gtgggtcagt cggccgatac aagcctagta tgcagacgcc gcagggcttc ttcgaccctg 33360
acagcatccc ggaagacacc atcacgttcc gcagccgctt ctccctgccg tactctgtgg 33420
cgaatgtgac tgtggagggg agctactggc cggcgaccgt gacgatggcg caaggggact 33480
tcctgttcag cgtcgactgg tccacccgta accgcctgct gcaggactca ccggttcagg 33540
ttccgtgggg tgccggcagc atctcgccgg aggaaggaac tacctttgtc gccgaactgt 33600
ggcagggctc tactcttgta gccaccagcg gcgaggtaac agggacacac gctgatattc 33660
cgttgtatgg cgtagccagc ggcacgtata ctctcagggt gtacagcctg cgcggcggtt 33720
atcgtaacta cattgactat gagcacacat tcaatctggt agcgcctgcg gcgaacacag 33780
gatatgggaa tggctatggc tttggttatg gcgtatagtt caaccaatat ttgattattc 33840
aactgagggt atcatggcgg cgaaacaaga tcctgtcctc ggccttaact acggctggct 33900
actcggcgaa gacaactgga acaccgggat ggacgccaac cttaaaaagc tgggcgccct 33960
tgtgatgggc gccgcagcct cggtagctaa tacgccggcg gtcacatcca atggcgccag 34020
gtatatcgtg ggggcttcac cgactggtga ctttgccggt cagtccaaca agctcgccgt 34080
gcgcatcgag ggagcctggc agttctatgc gcctgcagca ggctgggcgg tgttcgacct 34140
gtcggtgtcc cgctatcgca tcttcaatgg tactacctgg gcgctggaga aggccgtcat 34200
tgacgcacgc agcttcctgg aagcggctaa cccgggctcg tggacgttcc cgacggcaac 34260
ctggatgaag gtgccactgt acacggtaac caccgacacc gcgaatgcgt gggatacctc 34320
gaccaacaca gactatgtcg tacctgcgga cgggatgtat caggtggatg caatagtacg 34380
cccgatccgt tctggcacag gggcactgcc agacagcacc tctctggcag taggcgttgg 34440
cacgactgct gcagactcaa aagacgttgt ctggggcgcc ggcctcgcga cagcactccc 34500
attttcgctg gcggtctccc gggtcctccg ctgtgctgcg ggggaccggc tatccctgtt 34560
cgcccgtcac gcggctgcgg gcgcggtagg gatggcattt gccagcctga ccattctcaa 34620
tctttcggaa taacgagggg atcatggctg attacaatga gctgtacaat gaaatgaagg 34680
aagcagtggg agacttgtcc gcgtcttccg tagaaatgaa aggtatgcta acagcgggag 34740
aggataccga cgtcaacgtc gaagggtacg gcccgaagcc ttccttcagc aaacagataa 34800
aagagctggt ggtcgggaag tcggaaggta tattccggct atatgcgaca ctagccgacg 34860
cacaggcgga cattgctaat actccagttg ggtctgtaac ctatgtccgg gggtccgata 34920
gcacctccct ggccgatgag tacatcaaca atggcggcac cctaactgcg accggacgga 34980
cgatgccatc cggggtcgcc gttgagatca tgtccgctac cgtccagcgt ttaatgacgg 35040
ctttgcacgt tatggcggag ggcgacgccg gttcggtttc aggtattgac agcagcgata 35100
ctgtgcaggg cttgatgacc ggattcaacg tactggcgga gtcctttaat aacctttcag 35160
tggaaagtca gaaaaatgcc tccggcctgt ccgccctggt ctcatccgtc cagatctgca 35220
ctgaagcact gaatacgctg gcggcccggg tcgtgacccc agacggcgcg tcgcagtacg 35280
actatatggc attttccacg cccggtaccg tcaacgccag taacgggacg ttcgggggca 35340
acacccaata ccgcagaacc gggatgatcc cggttcgcaa gggcgacgtt gtgcgcctca 35400
ccgttcacac cgcaacgaca gtcgcaggcc acgccgccgc attatatgac acagcgggaa 35460
catatgtggg acccctgggg atcatgtgcg ggacgtatgc ggcgtataag gcgcggtatt 35520
accagtgtga aattacccag gatggatttg ttgtcgcaaa cacgctggac cagagcgcgt 35580
ccccttctgc agatgtaact ggtgcgtcac tgacgattga ccatcgtctt cgtggccggg 35640
aagcagacac ggttattaag ctgacaaagt ctgatttggt cccggtccgc ctggataacg 35700
ggaacatcaa cgccagttca ctcacccagg acggaatcgt taactattcc accgggctat 35760
actcctgtgt gggcggcaga ctcctgttta gcgggttgcc tgtggcctca tctcccggcc 35820
agagcagcag tctctacaac gtcgtgtttt atgatgccgc caagactctg atcgcatatc 35880
gtcctgtctt ctccagttcg ggatatgtga ttatccctga aaatgccgcg tactgggcgc 35940
agcagataat caccgacaga acgcccaact ggtccgaggt ctcgatagtt tactacaact 36000
acgtctacaa ggatgagcta cacaagctgc tgtcgtcaga acgcgagcgc ctcggactga 36060
actatcccaa cgaatattgg ctgcaggatt tcagcggcgc taccgatatt gagtggatcc 36120
agaacgcaat ggactgggtg catgatgctg gcggcgggtg gttgataata tcatccgatt 36180
atgtaaagcg gcagttcatc atctccgaag cggttatcca ccgcagcaat gtgtgggtag 36240
ttctcgatgg tgtcgagatt aagctgcagg acggcgtgca tgacaatctg tttcgtgcgg 36300
caggggttat tgtcaaccct gccgacccgt ttggtctgtg cctggacctg gaaattacgg 36360
acaatgtccg cctgattggt acgggatatc cgaagttaag tggtgccgat gtgccgtatt 36420
atgcggatat ccccgcagga accgggccgc gctactggat cggcgacgaa tatggatggc 36480
gcggcaccgg gctgatttat tacggcacgc agaacttcga gattggcggc ttcaaactcc 36540
agaacgtaaa aaactggggg actgatttcg ggtacggttc taaaaatggc tatatccacg 36600
atatcgacct gtggcagccg aacaaaaacg gcgacggcat ccacttcact aacggggcca 36660
gtcatatgcg cgtccgtcag attttcggct atgcgcgcga cgactgccta gctatggtta 36720
atagcgacga ctccctggtt tacggcccgg acaaagtccc gacaccgggg tcaattcgcc 36780
agtggatcta ccctacatgt ccattctggt atggttgggc gggaaatgag gccgtgggga 36840
ccagtaacga catccacgat atcgttgcta cgaatatcgg gttaaccggt aacgagcagg 36900
tcagcaccat tctgaccacg cagtttaaaa tctacaacgt gacaatcagc ggtatcagca 36960
gcgtcaacta tatgactcca ggccggggct gggatgaagt taatgcgatt ctgaaatcgt 37020
atgcggcatt tggtgacggc tccaggtatc aggcaggtaa tgtcagcaat atccggatta 37080
acaacatcat tgagtgcgca tcaaaaaatt acagtatcga tataacgctg gaagggcggg 37140
atatccgcat caacaggtat atgaaactgg acacccgtgc gaaaacaaaa ggcgcgctga 37200
atatcagcag ctcggcggcc ccgaatgtaa caacctctaa catcgtggaa taaacagatg 37260
actatattga ttcaggattc attacgtcgc gccgttgaag cggcctcccg cggtgcgcag 37320
accgtgcttt atacccgatc tggcgacccg tcgtttgtga atatcatccc caagtttgac 37380
gtcagcacga ttgatgcttc gctgggatca ggaacacacc cggcgtttat cattaacggc 37440
accgaggttg accagatttt cgttggcacc taccccggct gtattgttaa cggccaactg 37500
ctgtcccttc cggaccggat acccgccacg tcggtggcct atgatacggg catcggtctc 37560
gcccgggcgg ccggcatcgg ctggcacgcc atgacaaacg cggaatgggc ggcaatcgct 37620
ttgttgtgct atgcacaggg gcaatcaccg cgcggcaata ccaactgggg gctgtcatcg 37680
gataacccca gcgagaaggg gcggcgggca gacgggctgg ccgccgggac cgaatccgga 37740
acgggtctga cgctgaccgg ctccggtcct gtcagctggc ggcacaaccg cgactatgca 37800
ggcattgcag acctggcagg caacatttgg gagaccgtta ccggggtccg tttctgcggt 37860
ggcgagctgc agataatggt caataacgac gccgcgcttt acaccaccga ccacacgtta 37920
tcctcaacgg catggaaagc cgttagtggt gtggatgggt ctcttcttac gccgactggc 37980
accggaacgc cgggaacagg ttcatatgtt ccaaccacac ctaactcagt tcgtatcggc 38040
ctttcgggga ccgggaatta cacactgatt tatggtgaaa atacgctgtt caccagtgcc 38100
acgaaccccg gggctacgcc ggtatccgat gtcgcgctaa gggtgctgcg ccgactgatg 38160
ttgttcccgc tgccgggtct gatttccgac gactccttat cgtataaagc gggcggggag 38220
gtcatgacac tccgcggcgg ggcgtatacc aacggggctg gcgggggcat caacgcgcta 38280
ctcgctaacc gtggacgtac ttcagttggt cgatctaact ctggtgtccg tcctgtttac 38340
tacaagcctt gacattaatg cgccatacgg cgcatttctt tcctctttcc cggcgtggtg 38400
acagaagatg tttatgagga ttagctttaa aaagtcgaaa tggtccctct tgttatttat 38460
taaactgatc accgtggcaa tgttgactaa tttatttggt attggatggg gccttctggc 38520
tgttgcggta gtggagtctc ttccatccat cgagattaag aggtcgatgt gaccgccttc 38580
gggtccacga aggctatcac ccccgataat ggatgagtct agccgtggcg tgggtgcggg 38640
gcctagtttt ttttgtcgtt acggatagtg gaaatttcca ctggaagtgt ccagaatagt 38700
ccgaagcgat ccgctaaccg actacaggac tattcttatg actgatccag ttaccaccgg 38760
caccactctg acggctgcgg ccgccggggt cggtgccatc ggctggtggg ccggacttga 38820
cccgggcacg gtcgtcggtg ctttcaccgg cgccgtgttt tttgttacct atgcaaaaga 38880
gctgacgacc cgggcgcggt tcggctatgg cttcgtcagc tttgttttcg gaatagtctg 38940
tgcgcaatgg tttgccgagc tgctatcgtg ggtagtgagc gccttcgtac cgggtgacca 39000
cagcaaagca cccgttcccg ttggcgccgt ggtggccgcc acactagcga tcaggatcct 39060
cacggcgata tcgacaaagg aattcagcaa cgccgttatt tcccggctgc tgagctggct 39120
gcaggcggtc gtggctaaac cgaagaacgg agggtcagaa tgaacgacct tatcgctttt 39180
catcaggacc cgctggcacg ctggctgatc gtcctgaatg ctattgtctg ctctgttatc 39240
gttatccgcc tgctcacttt taagcgcgat ggcgccaagc ataaggcctg gggtggtttc 39300
ctggcctggg cgctcatcgt gctctattcg tggcgcccca tcactctggt aatggagatg 39360
attcaggggc aggtccacat ggcaatcgac tggacccaaa tcgggataaa cgtggtgatg 39420
atgatcgcat tgctgcgcct gaagggtaac gtgatgcagc tcttcaaaat ggccggtacg 39480
ccccggcgac aacattaacg gccttccgtg gccgggtgtt actcggccgc gtccgccagc 39540
ttattcaccg cttccaccaa ctcatcgtgg ctcatcggca ggatctcgta acttgcgtcc 39600
gtgaccttga acatccgatc gctcggcttc cctttgctgt ccatccttcg gtacatcagt 39660
ccgaaagcac cattgacata aacttccccc aacgctggcc cacgagcgaa cacgcagaat 39720
tgggtgcctg cccggtaacg tatgctgtgg gtgcgaaggc cggccacttc agcgccgttc 39780
acaccagtca aggtgctgcc attaatattc ataataagct ccagtcagta tcgatcttat 39840
caccgtacag ctcgcacaat cggctgaagg tgtcccagca atgtattacc cgcactcctt 39900
cgccttcggc atacctcaga cagtttgctg tgccggcgtc ggtgccgtcc catagggaga 39960
ggatgacgcc agagtagtcg accatccaca tgttccgggt ctgcatcttt accgcgctgt 40020
acccgccagg gctgacaacc tcgacccggt tagcccgacg cagtatcctc cggtaccgca 40080
gctggtcgtg gtcccgccat cgagcctcct ggccgcggaa aggtatcgcc gccgtcaacg 40140
ggataccgtc ctccagagcc accagcgcca gcgccgtatc ccagcccagc gcaaggccgc 40200
ttacaagttc actggtaccc gcagggagca tgaggcgcac ggtgcgcttc atcacgtcca 40260
tcatcagcgg gtggtagccg agagggagct tgtctgggcg gtgcccggtt cccgcaacaa 40320
tcacgctatc tccccctcat agattgcgtc ccaggtctgc tgctcaccct tgtgcatcgc 40380
ttcgatcgta ttaccacaac gcgggcactt agccgcggta acagaacccc ggaaggcaat 40440
gcgcagcggg aatatttgtt ttagagactt ttggttgagt tcaaacactt cgccacaagc 40500
gtcgcacgtc ttcatgccgg ccatcgggta tcccctctcg cgactttcag cacgttgcgc 40560
cagtccttca ggctgaggtg ctgcatcata tcgctggcct tcatccacga agagccgatg 40620
atcgacccgg cggcgccacg tatcatcaac cggtaggtat tcgagtggtt gttccgccag 40680
gtctccagcc acacgtagcc cgggtcgtcc cagtcgacgt tgtggcggat attcaggttt 40740
ttgaccttcc ggtacaggtc cgcaggttta atcgccttcc gtggctcctg ctggcgcagc 40800
ttcatctatc gccgggcgcc gttcggcgac cgggcataac ggctggtgat catccgcagg 40860
ccggcccaca tgacaacccg gcgagcccag cgcggtgttt tggggtgaat ggctacgcgc 40920
agcagcaata gacggaattt gtgtacctta aacatctcgg gtccttacct gtccttcgac 40980
aggcgcttag gggaacagta ggcgatgatc gtggtgtccg accccacctg gagctgcagg 41040
cgcgtgttgt acgccttccg ggcggccgct tcgcacgcct cgacggtgta gaaggtctcg 41100
gtcaccggtc tttccagcac gccggcggac aatacccaga tgaacaggat gctggtcatg 41160
acggcgtcac cacgcgtgga ggtaccggtc cgtagatagg gcccaccaga gtccagccgg 41220
cgatcggcag atcgcttatc gagtaggtga cacacccgct ctccgttaca aacatgtagc 41280
cgagaagcag caggttatcc gcaacagagg gcttgcgggt tttgatatcg tacagctcgc 41340
gaatggcatt acggaccaga gtcggcgggt ggaacgtgaa ctcgtgcccc tcagacgtat 41400
tcaggtagtc agccagctgc tcgacgggca ctggctggta ttcatatcga tccacataaa 41460
gtccttagac cgggatgacc ggtcatagaa atagcttgca aaagttacgg agagcttcga 41520
cctcatcagg ggtaaccctg aatccgggtt tactcggcgg ccagaataca ccgcgtcttc 41580
ctgatttagg ccaatcccat tcgaagcggc actcacgccg gtggaatctg acaaagtaga 41640
gagcattcag ttggccaaca acgcctcccc acgagcgccc cagaaggtag caaattctct 41700
ctatgctatc accacggcgg accgctttaa tcaggtatct tttctcttca tcactccagc 41760
gtaagccctc tcgcggtgct ggtgctgaca ctgagataaa cagcttatcg tccataactt 41820
cacccgaaaa accagtacca ggcgcagaag gagcccacgg ctgccaagac gagggcgatg 41880
acactgccca tgagtacgag ctggacgaac ggatcgccgc cgcgcatatc ctcgacgtcg 41940
cggaggaact gctcttcgcc agcctggcgc ccgtcttccc atgcttcggc cttccgttcg 42000
tccacacgcc cgtcgcgctg ggcgtaggga ttctcttcag ggcggaggcc ggcctctccg 42060
gccagatagc cgcggtgcca cacaaaatca ggtttgctca taatgacctc agtatgaaaa 42120
ggctaacacg gccggtacga tcgcgtagtc cgcgaggatg cgcttcgttt cttccggcaa 42180
ctggtcgatc tccttccggt ccagccagga ctccgcctgg cgcgggtcgt ccaccagctc 42240
ggcatacttc tccagcctgc cgttgctgac ccgggtagat agtttgacgt acttgccgga 42300
tgactggtcc ttgaccagca ggaccgtcat ctgaaggttg aaactggtca tacggcgtcc 42360
ctcgcatctg gagcgatgtc catctgtgcg ttgagtaaac atttcagccg acgacgagcg 42420
tctttggcat tccgctctat tacagggcgg tcggcggggt cctgagaacc gctccaggac 42480
aagtctatct cggcagcgac gagctctgag atggcttcgt tgatcgcctt acgttctttg 42540
acgttcattt tggttcctta gcgcccgata gcgccgcgac gacgttcaag tttagccttg 42600
cgcttagcag ccttacgggc gtctaccgcg cggttgtgga tctcgatgtc acgctgctga 42660
cgccggcgag ccattagtac cgcttgctcg ctttgcagct tcgcgtagtc cttattcagg 42720
acgtcgttag cctgagccag ctgttcatcg ctcatctggg ttgactggta agcaccgacg 42780
ttgaaccgca gcaggttaac tgtattttgg acgctggtga ccattgaatg ccgttgcacc 42840
agatggacaa attctgttat cagttcttca cgttccacgt tgtttcctta gccctgacag 42900
gcgtgtttgg ttttcatcat tgatactacc accagcggaa taatattcaa cctttagttg 42960
agtgaattta cactgggcat gaaaaagccc cggtgaaggg gctttgggtt aatcgtcttg 43020
tttgacgcag atcacgtaga agtcgggcca ccggtagatc cgtccttcgc tccagggccg 43080
ctcactgagc gaatagctga ggcgcagttt cccggggcgg ctggtggatt cccgcacccc 43140
ggtaataggg cgcacggccc ccagcgtctg ccagtccata cgcccgatca tgatgtcgcc 43200
cggcttcacg tcgcgcaggc gcttcatcac gagccggggc ttcaggtgct tcggtgcaga 43260
agccacccgc tgaccgggga agaagctggg catacgcggc gagttcttca ggatgatgat 43320
cttatccagc tctgtgctca tacaacctcc ggatcaattc tccgagggcc ttaactgcag 43380
agtaaatcca ctccgacaga gcgaatggca gtatgaaagg ccaggcgaac gtgaacagca 43440
cgacgtcagt ccggtcaaag gggcacttac ccaggccact aatcaggccc gctaatgcgg 43500
ggatgcagat gagtccagcc aggtacacca gcaggaaggt agtcatacgg atttaccccc 43560
ggcggcttta cggttctcga tgcggtggtc ttcgcggctc atgttgtagg ccagcttctc 43620
cacgatagcg cctgccacgt ccatgttcag gcccccggcc aggtccatga tgcggatgac 43680
ggcgtctgcc agctcgactt ccagcatccc ccggtgagga attttgtcgt ctttcagccc 43740
tttgcgatga ccttccatcg cctcggcgac ttcggtcacg atgagcatca gcttcgcgga 43800
gacccagtta tcgaggtgct tcttcggcca gttgcggacg tcttcccctg tctccaggtc 43860
tgtccaccac ccggcgttgt tagccaggcc gtagcagacg tcctgcagca ccagcaggcg 43920
cttgacgacg tcgaggcgcg ccggttcaac gacatcagcc agcttatcga ctgcgtcttt 43980
ccagcgccgg atagccgcag ggtccgttaa tgggtccggg gtattgtcgt tggccggctc 44040
tacggcacac ggtttgccgt ccagcagctg tgactccgcg cgtccgcagt ggcggcactg 44100
gtccagcacg acttccccgt tgcggtcttt gatctgctcc ggcgcatcag cgtcaccggt 44160
gctatagagt tcgtggctcg ggtggcacgg cttcgcgttg taggggtcgt actccgcctc 44220
ctgagcaggg gcgctgtagg aggcgagttc attattggcc ttaatcaggg ctgcgatatc 44280
agtcgtgcaa ccattattga taatgcgcac tggggctgca aacgtcgcaa attcccgatg 44340
cgacttttgg acggtcaaag cgagattaaa taccgcggac gccagcttat cgatcagcgc 44400
ggagctttcg cagtgggtga aggcttttgg cgcccgggcc atcactgcgg cgcaggaagt 44460
ctttatctcc aggatgtctt tgtcgaattc gcggctaacc tgttcagctt cagtgggaag 44520
ctcaccgtcc ataatttgta ccagtcgggt accgggaaac gccgtctgca cgtttaacgg 44580
tgttgcgcca gcagacatac gacggtagtc accgaggatg tcgagcacct gctgcacagg 44640
agagcggccg ccggactccc tgaccatctc agcgtcactc agatacttcc agacttcgcg 44700
ccatgcggat gcctgatcga gggtagatgc tttgccgtca cacacggaga tcagggcttt 44760
cgccaggtca attaccgccg aagctctctc cccgtgtttg tatccgtgct cgcggataag 44820
tctaattgct gcgccggact ctaggggtga cagatctgct aattttttgg cgagttcgaa 44880
aatattcttg tccatacgtt ctcctgattg aaaagtgatt tgactacggg attgagcata 44940
ccacttccgg gagaacattc aacctttagt tgagtaattt ttacctgggc atgaaaaagc 45000
cccggctgtc ggggcttcgg gtcaggcgta gtaggctgct gcgaaaacga ggatgattag 45060
catccagcag accgcttgca ggtaccatcg cagtgtgtcc gggtccatcg gcggccgctc 45120
gatgactggc cgggtcttcg ggtacttgtg cttatggcga tacttccgcc ggccgttgaa 45180
cttactcatt tttcgtggtc ccccggattg tcgtagtgac gcacaacgtg gcacgtgagg 45240
cccagcgacc ggatgtgctt cgccactcgg aggttgtctt cgaagcagca caggatacgg 45300
tcgaagccaa tgcgacgcag ccaggattct ttgaacgcag tgtccgggcg gtggtcaccc 45360
gtcggccgca taatcaggtc gtagtaaggt acctcgtgac gctccagcca gtcgtaggtc 45420
tcccagtgtg cgacattgca gcaactggtc agaatgatga tgctgtgcgt ttggctaagc 45480
gaccgcagca gacggatgtt atccatgatc ggcgcatctt tgccgcacgc caggttgaag 45540
gcgtcccagc tctcggtgcg gtccagattc tctttcggca ccagatgtaa ccggtgggcc 45600
ccgtcgcgca gtgtgccgtc taaatcaaaa acgataatgt ctttcatgga attccttagt 45660
cttcgtcgtc atcgagatcc ggcagcaggt ctacggcgcc ctggtgctgc gccagcagtt 45720
tctcccagtg ctcggtgtgc acccggaact ggcgcttctt ccaccacatg cagatggtct 45780
ttggtatcca catctggctg ccgtcttcca gggtgaccag cagcgcctgc gcggtcagct 45840
ccaggtcctg ggtggacgtc acgttctgcc acacgtcttc acgagcatac tgggcgtccc 45900
agtagtcgta atgccggcgg acattgatgt tctcaactgg ccgggggcgg ccgttgataa 45960
tccggttgat ctgctcgtct gcgtattcgc ccatcattcc tcccagtgga agaagaacca 46020
gataaggccg acgacaatcg ccgcggcccc cagtaaccat tcggcggtgt acatcatccg 46080
atggtcccac acttgccgca gacggtgccg agcgcccgcc catcctggtc ggtgtgcacc 46140
agccagtcgt gctcgcagcc tttcggatca gcgagaatac gggcctttgg gcctccgtcg 46200
tactcctgca ggatcgcctg cagcttcgtc ttcagcaccc gggagatgtg ataggccgag 46260
ccattgcgga accaactatc cagaatcgcc agcgcctcag catcgaggcc cgtgaatcca 46320
ttcacctgga tgtagacgtc catatccgtt gcacacggct tgagaagcgg gtcacctccg 46380
cagacccacg tcaggccaga gaccttgcga accgccacta cgctgttcaa tagcggaggc 46440
aggtcgtgtt tacgggctat ctcggcgcgc agctcgacaa tgtgcagcgc cttctcaatg 46500
tcctgacgac cgttcttctg gcggtgacgc gatacatact tcaggatgct ggacgtggcg 46560
aagtcgtaca tctgcgtcat cgcaaattcc atcggctgga tcggcatctc actgtaatgc 46620
gtaccgccga cctgcgtgtt taatgcactc atgagtcctc cgataaacgg gcaagttctt 46680
ccaggtcagc gcgctcgata agtttgccgc gcatctcctt ttcgagtttg ttttccatct 46740
tctccaggca gctcttcagc atccgcaagc cggtctcagg gaacgggctg gtggagatgc 46800
cgtcgagggt ggcccggagg cttttgttcg ccgcacgcgg cgcgatagcc cgcgcgcagt 46860
ggcgcagggc taccggtacg ctgcgcttgt ccagctgggc ttccttgcgc gccagctcca 46920
gcgtccagat ggcatccggg aattcggcgt acttcgacgc catgatcagg tccattggca 46980
caaagctcat ccctgacctc ccggtatcac gcaggtccac actgccagca ggccaagcgc 47040
cagagcgccg gccatccacg ccagggtgat cagcatctcg cgtttctggt tcggcatcac 47100
aggtcctcca ccggtgcgct gtaacgccat ttgcagatgg cgcgctcgga acgcgggctg 47160
ctctgtcccc gccgtttgca gtcagggcac tcaacgtagt aacggacgcc gccggcgccc 47220
accgtttgct tcacttccgc gtcgcccccg caggggcaaa cgagtaatgg tttgaggttg 47280
gctggcatca tcagatcagg tcctcatctt cgacgtcgcc agtaagtgac ttcggctcgt 47340
ccagctcttc gccgttgacg tggctgatct tccagccctt cagcgcgtct accatcgact 47400
gcacttcgtc gtcgctcatg tcgcgcagcg cttcaccgcc cagtgacacg acaacgccgt 47460
caaccagcga gtccagcgca tccacggtca gcagcagagt agccttcgcc agcgcgatac 47520
cggattcgtc ttccgtgtcg gcgccggcgt cgtcctgcgc catgtcgatc agcgcgtcag 47580
gccaggatac cgatttgaat gccaggtttt cgttgaggat gaagcgcgtg ccgccgtgca 47640
ggtggtcgtc gtagtagccc agctccagcg acacgacctg gtagtcttcg ctcagcagct 47700
cgctcagggt cgaagagtcg agatcgacgc ttttcccaga gagcacctgg gacccctcca 47760
gcttgccctt cgcagtgaac gcttcgccca ctgacagctg cgacgggaca accgtgccgg 47820
ctacccagtc cgtgaactgc gtgacgacgg gcttcttcgc cgtcagcggc tgcacgggta 47880
acgagccgag cacacgacgg accgcgccca gcaccagctc cgccttcttc gcgctggtgg 47940
tttcaacgta gacccagctg ccgctgatca gcacgttcac gcggctgtag tcgatcagcg 48000
cgttttccat catcccgatg atgacgtcgt tcttcaggcc ctgcttctcg tccttcgtgg 48060
ggacgcgggc atacttttct tcccagtcct tcaggcgctt atccagctcg cgcttgacga 48120
tcttgttcgg gacaatgcgc agcgcggttt ccagcgtcag cgcgtacttg ttcttcgcca 48180
gcacggtcag cagctcatcg ttgccgtcga tggtgggcac gaagcctgag cgttgcatct 48240
gaaaggtggc cggatcgccg gcaggcagca cagccaggcg ctcgggtagt atgtcgaacg 48300
gtaccttgtc tgccttcagc agccggtaca ccagaaaact cttgaatcct gctttcatga 48360
cagggtctcc tgcagtcgtg attatttttc ccgttgagcc gtctcaactg acgcaagaat 48420
actcaacaaa aggtatgttt cccaaacgga tttactcagc caaatttttg gaacgagcaa 48480
ggtttttgaa aattcaggga tttttgccga actactgggt acccttccag cggttttcag 48540
cgtggcgcca cggtgctgca gtttgcgaaa tcttttgccc aaccgaaaat tacacgcttt 48600
ttgagggggt cgggcggggt cgggtatggg gcgcaggccg cgcacgcgcc gcgctgccgg 48660
gcgttctctg gtgactgtat gcgacggtac agggtcgagg gttgcgccgc tcctgacgcg 48720
ttacagcgcg ttttacggcg cagggggtgg cggggtcccc tttcgggggt cccctttcgg 48780
gggtcgccgg gcgctggcgg ggccgatcaa cgggcataaa aaagcccgct cgaaagcggg 48840
caaagggcgc acggcgttac agactatcgg cggcgggggc gctggtggtt ggcgcggccc 48900
tgggcaatgc ccgcgcatac cgctaaggat agcacaaggg gcagcgggta caggatgacg 48960
gcaggcggca gcagcgcgga gatcttggac acgaccccgg accacggagc gcacaggaca 49020
ccgcccacgg cgacggcggc aaggtatagc cagccgtggc gacggtctgc cttgctgctg 49080
tcatcgcgtg gcaagttctg aatgttaggg taaggagatt gccagcgccc acggctcacg 49140
cgctccgcgc cgggcacggt ctccggctca cgccatccgg ggaacatcaa ggcggcgcgt 49200
tctgcgtcac tgagtgggga caagcggcag cgcggcagcg ccattttgac aacgcgcgcg 49260
gcggtcagcg tgccatcgtc acccatgaat gagaccagcg cggacccttt cggcagcgtc 49320
ccgatcacat cggcagcttt aaagcccacg ggcgcgggca tcgactgcgc ggcggcgtac 49380
actgcccggg catcagcagg cgtcaccgac cgcagcgcgt gctgtatgcg caggtgtagc 49440
tgccgtgaga tgctatccgg cagatcgccg ggtgcctgcg tggcgaagaa tacgcctaca 49500
ccttttgagc ggatgaggcg cacggtctga tctatcatgc gcagcagctc gggcggcgcg 49560
tcatcgaata tcaggtgagc ctcatcgagg atcattgcga aaatcggctt gtcagtgtct 49620
ccgacttcag gcagcagcgc cgccaggcgg tcaagtatca tcatgagaac ggcggcatag 49680
agccggggcg cacgtatcag gcgcacgcag tcgagcattg agacaacgcc gcgcccgtcg 49740
ggggtatgcg ccagcaggtc agcaagggcg aacgtggagc ggtcaaagaa ggccgcgccg 49800
cctgcgcgtt caaggcccag gatcgcccgg ccaattgctg cgacgctcga cggcgtgatc 49860
agaccgtagc ggctgccgat ggcgtcccgg ttctccgcgc aatggttcac cacggtgcgc 49920
aggtcccgca acgtgtcgag cggcagcccg tcatcctccg caacggcgaa agcgatctct 49980
atcacgcccg cctgcacatc ggtagcgccc agcgcacgcg ccaccagcgc gggacccatc 50040
gcccggatcg tggtggtcag cggtccgccg cgctcccgga aaacgtccag caggcgcacg 50100
ggcgcggctt caggtcgcca gccggggaac tccttcgcgc cgtcgagcgt cgacgccgcc 50160
gccatccctg agaggtcgcc ttttacgtct gtgaggaata ccgggacgcc gatccgcgcc 50220
agcgactcag caagcccgat tgcgctcacg cttttaccgg tacccgttgc gcccgcgatc 50280
aagccgtggc ggttgaggta cttcgcaggg acgaaaacgg ggccgcagtc ggccccgatc 50340
ataatctggt agttagtcat cgttcaggac cccgcgaata taaatttttc accgaaagcg 50400
cggactttgc agcactcaca gcgaaaggag ttttcgccct ccacggtctc cgccattgag 50460
agcggaccgt gtgcggactt caggagggca taacctgaaa acatcgcggt ttcacgctcg 50520
atcggcatat cctcgatctc atcgttggcg atgtagttcg cgcagctggc gcacagttcg 50580
aaagtaatca taattcatgc tcctgcattc aggccgcgca gggcgacccg aaagtaatgt 50640
tttgcgagga tccgcgcttc agtggtcctg atggctgcga actcacgcgc aagccggtag 50700
gccgggtgat tcctgtatgc ctgctgccgg ttcatatcag cgactcctgc acctcgatta 50760
tcaggcactg cgccggcatc tcatccgcgc ggctcgttac cactatcgcc gccttttggg 50820
tgatgcttac gccgatctgt gaggcggcgg cgctaaactg tttttgcacg cgggtaacgt 50880
cgccgccatc gaccgcccac aaggtgcggt cgccgggctt catagtccgc agtaaatcta 50940
tcttgctgga taccgggttg atcatcatgt tgaatattcc acaaatggtt gaatgttagg 51000
accagcacga gactacatag cggccttcgc ggtttacttt cagcttctcg cctactttaa 51060
tttcaggttt accgatgctt atttccccgg cctcgatctt ctggtctacc gctgcggcgt 51120
catcaccata tgctgcgtaa tagctgaccg cgtcggcgtg tttctcctgg tagtcggggg 51180
cgctgtctgc gtcctatgca cttaatgtaa taccttacag ttgtattgtc aactattggt 51240
tgaatgcttt tcgcgttctc ctgtggtgct gaccgtggcg cgggcggcgc tgtcctgggg 51300
cctggtctgc gtgctgccct gctggccagg tctcacggtt tcactgtgcg cgccagccag 51360
gcgggggaga atcccatcaa ctcaatgaac ggttgagcgt aggccgcgcc agcctggcgg 51420
cgtgatgcgc ggcggcggtc gctttcaggt cggagggtga ccgggtcgct cggggtccca 51480
tcgggggtgg ggtgggtcgc cgcgggggac gcggagcgcg gttttcgagg aatttcaaaa 51540
acgtcaatag ccccctacga ccgaaatcgt ttttgtttcg ttcgaaagtg agggctttaa 51600
gttattgagt taaaaggttt cgcggttact gcggggttag gatttatccg atatgtggat 51660
ccccatatcg ggccccttag atgagttcat cgatatcgtc atccgccggg tcttccggtt 51720
tcgcggtctc cgcggtttct tcgtagccga tgtcgtccgg gatcagctcc atgaagtcgg 51780
ccacattcag gtggtcccag acgtcgttgc gctcggcgcc atccaccagt tcgaagattt 51840
tcttcaaggc cgcagtatgg accgcgggcg caatctccac cacactgtcg atctgcgggt 51900
tatgcttcgg ccagaaaccg tatgtacggt ggcactcgtg aaaggcggca tcgccggccg 51960
gtaggctgtt cttcccgttc cacggctgcg ccagcgagac ctcgaaggag aacgtgcgcg 52020
gggcgaacgc gccggggttg tcgtcggact cacggtaggc ggtggctgtt acgaggtatt 52080
taggcattct taccccctag atcagttcgt cttcttcggc gtctgctgct gcctgcgggt 52140
gcaggtagtc accgatgccg cgggtgtacg ggatgcggag ggacaggccg atggtggcgg 52200
tggtgaacag cacaagagcg gtaccgaagt tcacccctgt cttcatcgtc tggccgtccc 52260
gctccatgaa attgtagcgg ccgtctggct cgtacacgat cacgtcgtac tgcaggttat 52320
cccgccacca gttcgacacc ggctcgtagg gcagcagcat catgccaggg cggccggcag 52380
cctgctgctt acgggcgtgc tggatgaact ccaccttgcg gtcaaacggc ggattgcacc 52440
accagtcggc gggccagtcg agctgcaggc tgtcgtcgcc acgatcgagg ccgaaatagt 52500
ccacgatgcc gcacttgctg gtggccttct ctgccgcgac gtcgaacagg aacgggcgcc 52560
cgtagaggtg ctgcgcgtca tagaactgcc gccacgaggt ggcccagaaa ttcttgtccc 52620
cgtcggccgt tgacgacttc ttgccggggt taaatgatcc agccataagg ctccttaaaa 52680
cgtcagttgc gaattcaaca ttcaggtgag attctggcac aggttgaggt cagtattcaa 52740
ccaaatattg aatattcttc aggaggtatc atgatccaga aaatactcgg tgctgtcgcg 52800
gccattctgc tggtggtcgc cggcacgctg gcctttcagc tacacggtgc tcgatcggag 52860
gtcagcacgc taaccagcga ccgggacgcg gctaagcagg aggccagcaa cgcgaagcag 52920
gcgcaggcgg tggcggaggc gcagaacgct ctgctcgccg gtgctttcaa agccctcgat 52980
actcggctgc agcagctcgg caccgaccag aaactcaaca acgaacagct cgcccgccag 53040
atcgaggggc tgggcaatat ccagaaatcc gaaggagatg acccaaatgc gattacatgc 53100
cttgataccc gtgtgcctgc tgagcttgat aagtggctgc tcgacgcccc ctacgaccca 53160
gccaacggtc atcactgagt acaggaatgt ttacatcccg gagacaatgc tcacggcctg 53220
cgagaagacc gcatggcgtg gcggcaccta ccgtgggctc gcggcgctgg cgaagtccag 53280
agggaccgac gtcgataact gcaatgctca gcttaaagcg gcaagggact atcagaacga 53340
tctgagggct cgtgaagagt caaaccgggc caaaaagtag gatgtaacct aataatccgc 53400
cgattacctt ttattttggg gcgtcggcgg attaggtatc tccccgaact ggttcaattt 53460
catatagata gccctcaaag ttacctaata actcaataac ctaatatatg aactacacat 53520
atgtaaatat tgtcgtcgta catatgaacg gtgagatcat gtgtcacaca tataaataca 53580
tatgcacata taaggggtag gaaagattgg gtaacttcaa attttaggta aaaacgctcg 53640
caagcatatg aaaaataaca tgaaagtgcg cgtacccatt cagtaacatg acctctttat 53700
caggtaacag gtaacaacaa aaaacccgcc gaagcgggtt ttgtttaaat caggtcgtca 53760
ttttccatat catcgccttc accttcctcc agcgctcgat gtttttccag cgccttcttc 53820
agcatctcct tgcccctgag actgagcttt ccatcctcct gaaggagaga tacgtccctg 53880
gtatagaccg acagcttcgt caggttgcca tcaattctga ccaccgtatt ctgcgcggct 53940
cggaatccct gcggcaccag aaacgaggct ccgctcttcg tattgaggct tctgtcgacc 54000
ccgtggatct gaaaagcctc cttcagatga gacatgatga ggatgtcgct ggtgatgcac 54060
gggtacctgt cgtcatcgag caggtcctgg agaatcgtct ctgcttctga ccgggcgttg 54120
ttagccacta tcgtccggta gcgcgtgcgc ggggcacgtt ccttcgggcg ataatactcg 54180
ctgaactggt atttctcgaa ataggctttg aactgccacg ggtggtcctt aatgtgctcg 54240
tacagcgtct ggacatagtg caccccttcc ttctcccggt tggcctcgcg ccactcggtc 54300
accgcgtcgt ccgtatggaa gcgggtgaac accaccagat agcggtcgtc gctctcgtcc 54360
agcggcaggg cgttctcgtg gttggtcatc atgtagaagt tcgcgaggtt ttcctgctgc 54420
tcggcatcct tgttcatggc gcgcacagag gccgtggagt tcgaaatcag tggcttcatc 54480
ttctccagaa ctgcgtaggc ttccaggccg ccgattttca cctcttccag accaacgaag 54540
caccggttcg aaatccagcc gttgtgcttt tccttcagca cgtcgttgtt gatctcgttg 54600
cagttctgtt taccgagcat acgggtgatc agcgtcttca gcgtggactt accttcgtta 54660
cgggacccct ttaccagcag cgcatacggc agcttgacgc ccgggaattt cacacaatga 54720
gcgacgaaat cagacaccag agcgcgctcg cggtcatccg ggaacaggtc cttcatgagt 54780
cgtttataca gcttgacgcc ctcgttaccc cggtacgcgg tgcgctcgat gatggcaggc 54840
cggtagaggt taagcaggca ctctccaccg acaataggca acctgtcatc cgggtgctgc 54900
gggtcgtagg tagtgcgaat ggcgcgcggc acagggttat tggaccccag agctgccgac 54960
agagccggga tgcgcggtgt cccgttctcc gtcaccccat aggtgtcgat cgcttccttg 55020
aagtagcggt tgttgaacgc ctctttcccc ataggacgca tctcattgtc tgacaggcag 55080
tagaatgcgt tctcgctgac cacgaaaacc acgtcgtcca gccattcagg gcggttatca 55140
tccccgtttc cgatgagccg gttaaccttc cgctcagtga cttcctttcg aacgaaagcc 55200
ttcgtcatcg gcgagccaag ctctttggcc ttttcgatga ttttcgggat gaagttctcc 55260
cggcgccacg cctgcaggaa gtcggctggt gcgccggcga tggcatggca taccttctgc 55320
aggtcgtcca cgttctccgc gatgcggatc aggcggaaca cctcggtgca gtattcctcc 55380
agggtcttcg gctttttgcg cttcggagtg gtgtcgccga taaggtcgtc ttcatcgtcg 55440
tcctcctcat catcgccaaa atcaggcagc agggcagcgg ccatctctgt ctgctcttcc 55500
tcaatctcgg cttcgatctc cgccagcgcc tccagcacgg caggctgctg gcgcatcagg 55560
gcttccatcg ccttgtacga ctccagctct accggcgagc tgatatcatc cttgtcgatg 55620
ccgtcatcca ggtcgccgaa cagcaccaga cgcccggtgt caaaggtggt gtgctggccg 55680
tgggccacgt cggagtgcga gtggtcagag tggataaagg cgtcgtcgta gatgcggact 55740
gacgcggcgc cggaggcacc aaacgggcgg taacgtcctt cccccacata ctcgtaatgg 55800
tcagacagga actgctcgat gaagtcttcc ggggtgtacg cgcggtggac ggccgtgata 55860
ataggggctg tcgttttctt gtcttccggg tgctgccggc tgccggtgat gcctttggca 55920
ctgtcgacgc catccgggcg aacaggccag ctgtcagggt cggtaatgtc gtactttttg 55980
aacgcctttt tagggtccag gaacttgcca tcgaacgtct ggtggaagaa ctctccatca 56040
gagcagacgc tgggcataaa catcagctgc gcggtcacga atgactcagc ggcgacggcc 56100
atcatattct cgtcaaccag ctccgcgacg tagcggacca ccagctcgta ctcatctttg 56160
gtgacatcag cggccagcgg cacgataacg cggaaacgcg gcttctcgat ggtgtgcttg 56220
cgggtggtgt ggacgtgata ggccaggcct ttgagcccct ctataccgcc gcggtagata 56280
atctcgtccc agacagtgtc cgcatggtca tcgatgtcta gcgtaacgac cgaacggcat 56340
tccagattca ctttgcggcg cttgccgtct ttgaactggc cgcctacgaa atagccctta 56400
ttcttgaggt tgcgttgctc ttcaaccgac atatcgaggt agtcggcgag ggtaacgtca 56460
tcgcgaactg gttcttcgaa acgagagacg agttcctgcc acgtcagctc ttcgtttttt 56520
actaccgaca ggtttttctt acctggcttg ccgaaggaga ccttcagcgt gcgggtttga 56580
ctcatatcag ctccctgtca cgcaagtctt ttaatttgag ttcgatcagc tccagcattg 56640
agtctggaac ggtgtggtac ttccccgaat gccagtcctt tgcccgctgg taactacgtc 56700
gggttatggt ggctacttgc tgcagggtca gaccgtattc tttgactagc gaacgaaact 56760
tcgcagtatt gggatgtata ctttccaaag tggagtcctc tgtggcgccg tatttagagc 56820
aatactatca gaggaatctt aggaggtgca actgttagcc gataattcga ctaacagttg 56880
aatcagatga cgaacttgag cagctcagac tggaggatat tgccgttggc gagttccacg 56940
atttgcttca cgcgcttcgg cgggactcgc ccggcttcaa tccatttgta gacgttctgg 57000
taggacactc ctaggcgctt cgccaggagc ataatgctgc gttttccctt agcgtccggg 57060
gggcacgcct gcagcagcag gtcatgcagc ggacctaagt ctccgtaccg gcccgctggt 57120
ttgatggtca tagttgctcc actcaataga tggttgaatg attgcagcat acagcagcca 57180
ggcattcgtg atcaagtaga acgcaagaac acgttgcaac acgcaaaaga attttcaact 57240
ttttattgaa ttgccgagat gacatgtgct taaatctgtt caagccgaaa acgttcggcc 57300
acccaaaaca actaacagta accggagaac attatgtcca ttgagaaggc tattgccgac 57360
cagaccgccg cgattgaaaa gaacaccgaa gcccaagaaa aggccaccga agttcagctg 57420
caggttttag ctgcactgca ggccctggcc gctgctggtg gtaccactac cgtcacctct 57480
gaaaagggtg caggcaaaac ccgcactacc aaaaacacgg ataaatccac tgatgcggac 57540
ccgatctact ggcacatccc gggcaccgaa gagttcggct ccgttgatac tgaagccgag 57600
tggaaaaagc tgaagaaggc gaaggctaag gctgtcaaga tcccagagtc gaagtaccag 57660
accctggttg aagcggccag cggcaccgac gatgaaggcg ataccggtga gttcagcgat 57720
cgtattcagg ctctgatcga tgaagttccg gaagagccta ccgcggatga catcactgac 57780
ctgttcaaaa agtatctgcc gaaagacctt gaaaaggcag aacgtgacgc ccgcgctgaa 57840
atcatcaagc cgattctggc cggcgtgaaa gcgccgaagg cttctgccgt gaaggacgac 57900
gaccgccgcg acgtcatggg ccgctgctgg tggtaccact accgtcacct ctgaaaaggg 57960
tgcaggcaaa acccgcacta ccaaaaacac ggataaatcc actgatgcgg acccgatcta 58020
ctggcacatc ccgggcaccg aagagttcgg ctccgttgat actgaagccg agtggaaaaa 58080
gctgaagaag gcgaaggcta aggctgtcaa gatcccagag tcgaagtacc agaccctggt 58140
tgaagcggcc agcggcaccg acgatgaagg cgataccggt gagttcagcg atcgtattca 58200
ggctctgatc gatgaagttc cggaagagcc taccgcggat gacatcactg acctgttcaa 58260
aaagtatctg ccgaaagacc ttgaaaaggc agaacgtgac gcccgcgctg aaatcatcaa 58320
gccgattctg gccggcgtga aagcgccgaa ggcttctgcc gtgaaggacg acgaccgccg 58380
cgacgtc 58387
<210> 2
<211> 648
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC16/01/N133_KPN_BP ORF9
<400> 2
atgactcagg atcagttccg acgtgccgcg ggtatcactg acgcgctggc gcagcagtgg 60
taccagccca tcaccgaagc gatgcagcgc ttccagatca acactccgaa acgtcaggct 120
gctttcctgg cgcagatcgg ccacgagagc cgcggtttta cctgcgtgag cgagagcctt 180
tactacaaag acccggagcg catcgcccgg atcttcaagt caggcttcga cctcaataag 240
aacggcaagg tcgacctggc cgaggtagag ttcgcgaagg gctatgtccg gaactctgtg 300
aagctggcga accgggcata cgcgaatcgc ctgggtaacg ggagcgaagc cagcggcgac 360
gggtacaaat tccgcgggcg cggcccgatg cagacgactg gccggcgcaa ctatgagctg 420
accgggcagg gcatcggcgt cgacctcatc gcggatccag atcgtctgtc cgacccgaag 480
gtgggcgcgc tggccgctgg ctggtactgg agcgtcaacg gctgcaacgc gctcgccgat 540
aaggaccagt tcaccgctat caccgtgcag attaacggcc ctgccaaact cggccaggat 600
gaccgggtgg cgcgctggaa actggctaaa tctgttttat tggcttaa 648
<210> 3
<211> 426
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC16/01/N133_KPN_BP ORF39
<400> 3
atgactgatc cagttaccac cggcaccact ctgacggctg cggccgccgg ggtcggtgcc 60
atcggctggt gggccggact tgacccgggc acggtcgtcg gtgctttcac cggcgccgtg 120
ttttttgtta cctatgcaaa agagctgacg acccgggcgc ggttcggcta tggcttcgtc 180
agctttgttt tcggaatagt ctgtgcgcaa tggtttgccg agctgctatc gtgggtagtg 240
agcgccttcg taccgggtga ccacagcaaa gcacccgttc ccgttggcgc cgtggtggcc 300
gccacactag cgatcaggat cctcacggcg atatcgacaa aggaattcag caacgccgtt 360
atttcccggc tgctgagctg gctgcaggcg gtcgtggcta aaccgaagaa cggagggtca 420
gaatga 426
<210> 4
<211> 339
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC16/01/N133_KPN_BP ORF40
<400> 4
atgaacgacc ttatcgcttt tcatcaggac ccgctggcac gctggctgat cgtcctgaat 60
gctattgtct gctctgttat cgttatccgc ctgctcactt ttaagcgcga tggcgccaag 120
cataaggcct ggggtggttt cctggcctgg gcgctcatcg tgctctattc gtggcgcccc 180
atcactctgg taatggagat gattcagggg caggtccaca tggcaatcga ctggacccaa 240
atcgggataa acgtggtgat gatgatcgca ttgctgcgcc tgaagggtaa cgtgatgcag 300
ctcttcaaaa tggccggtac gccccggcga caacattaa 339
Claims (15)
- 항생제 내성 클렙시엘라 뉴모니아(Klebsiella pneumoniae)에 대하여 특이적인 세포 사멸능을 갖고, 서열번호 1로 표시되는 유전체로 이루어지며,
명칭은 YMC16/01/N133_KPN_BP이고, 기탁번호는 [KCTC18575P]인 박테리오파지. - 삭제
- 삭제
- 삭제
- 삭제
- 제 1항에 있어서,
상기 박테리오파지는 시포비리데(Siphoviridae)에 속하며, 전체 게놈 크기가 58387bp인, 박테리오파지. - 제 1항에 있어서,
상기 항생제는 카바페넴(Carbapenem)인, 박테리오파지. - 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 1항, 제 6항 또는 제 7항의 박테리오파지를 유효성분으로 포함하는 항생제.
- 제 1항, 제 6항 또는 제 7항의 박테리오파지를 유효성분으로 포함하는 소독제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170077537A KR101940019B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170077537A KR101940019B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190000944A KR20190000944A (ko) | 2019-01-04 |
KR101940019B1 true KR101940019B1 (ko) | 2019-01-18 |
Family
ID=65018125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170077537A KR101940019B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101940019B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102592971B1 (ko) * | 2023-06-15 | 2023-10-23 | ㈜에스에이치랩 | 장내 미생물에 대한 박테리오파지를 포함하는 피부 보습 및 주름 개선용 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
JP2015523850A (ja) | 2012-05-04 | 2015-08-20 | バイオコントロール リミテッドBiocontrol Limited | 治療用バクテリオファージ組成物 |
WO2017081709A1 (en) | 2015-11-09 | 2017-05-18 | Universita' Degli Studi Di Siena | Bacteriophage able to lyse klebsiella pneumoniae expressing a cpskkbo-4 capsular polysaccharide and related medical uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100965026B1 (ko) * | 2002-02-13 | 2010-06-21 | 이뮤놀로지 래보러토리스 인코포레이티드 | 미생물 감염증을 치료하기 위한 조성물 및 방법 |
-
2017
- 2017-06-19 KR KR1020170077537A patent/KR101940019B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
JP2015523850A (ja) | 2012-05-04 | 2015-08-20 | バイオコントロール リミテッドBiocontrol Limited | 治療用バクテリオファージ組成物 |
WO2017081709A1 (en) | 2015-11-09 | 2017-05-18 | Universita' Degli Studi Di Siena | Bacteriophage able to lyse klebsiella pneumoniae expressing a cpskkbo-4 capsular polysaccharide and related medical uses thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20190000944A (ko) | 2019-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10953053B2 (en) | Methods and compositions for preventing infection by a Vibrio species | |
KR100781669B1 (ko) | 황색포도상구균 특이적 사멸능을 갖는 박테리오파지 | |
KR101761578B1 (ko) | 신규한 장병원성 대장균 박테리오파지 Esc-CHP-2 및 이의 장병원성 대장균 증식 억제 용도 | |
KR20130087118A (ko) | 그람 음성균에 대해 세포 사멸능을 갖는 포도비리대 박테리오파지 | |
CN110612349B (zh) | 新型铜绿假单胞菌噬菌体Pse-AEP-3及其用于抑制铜绿假单胞菌的增殖的用途 | |
KR101237233B1 (ko) | 녹농균 및 황색포도상구균을 사멸시키는 박테리오파지 | |
EP3584315A1 (en) | Novel pseudomonas aeruginosa bacteriophage pse-aep-4 and use thereof for inhibiting proliferation of pseudomonas aeruginosa | |
KR20100035879A (ko) | 엔테로코쿠스 및 스트렙토코쿠스 특이적 사멸능을 갖는 신규한 리신 단백질 | |
CN113166730B (zh) | 新型猪链球菌噬菌体str-sup-1及其在抑制猪链球菌细菌增殖方面的用途 | |
KR101940019B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
US20210161978A1 (en) | Novel streptococcus suis bacteriophage str-sup-3, and use thereof for inhibiting proliferation of streptococcus suis strains | |
CN114703152B (zh) | 类鼻疽伯克霍尔德菌噬菌体vB_BpP_HN01及应用 | |
KR101824778B1 (ko) | 항생제 내성을 갖는 슈도모나스속 균을 용균하는 박테리오파지 | |
KR101789877B1 (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
KR101779262B1 (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
KR102264514B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR102193101B1 (ko) | 항생제 내성을 갖는 클렙시엘라 속의 균을 용균하는 신규한 박테리오파지 | |
KR101788401B1 (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
WO2021229397A1 (en) | Compositions and methods for inhibiting the proliferation of pathogenic escherichia coli | |
KR101915493B1 (ko) | 신규한 비브리오 파라헤몰리티쿠스 박테리오파지 Vib-PAP-8 및 이의 비브리오 파라헤몰리티쿠스 균 증식 억제 용도 | |
WO2023063453A1 (ko) | 항생제 내성 슈도모나스균 특이적 박테리오파지 | |
KR102011956B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR102011965B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
CN117241811A (zh) | 用于抑制产肠毒素脆弱拟杆菌增殖的组合物和方法 | |
KR20170052950A (ko) | 이질균에 대한 광범위 항균 활성을 갖는 박테리오파지 Shi-DYP-1, 이를 활용한 이질균에 의해 유발되는 질환 방지용 및 처치용 조성물 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |